<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2023.1207441</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of efflux pumps, their inhibitors, and regulators in colistin resistance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Yinhuan</given-names>
</name>
<xref rid="fn0002" ref-type="author-notes"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hao</surname>
<given-names>Jingchen</given-names>
</name>
<xref rid="fn0002" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1104578/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Weijia</given-names>
</name>
<xref rid="fn0002" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2318036/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Caihong</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Xue</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1745583/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jian</surname>
<given-names>Chunxia</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Min</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Guangrong</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Jinbo</given-names>
</name>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2060020/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zeng</surname>
<given-names>Zhangrui</given-names>
</name>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
</contrib>
</contrib-group>
<aff><institution>Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0003">
<p>Edited by: Mona I. Shaaban, Mansoura Universiy, Egypt</p>
</fn>
<fn fn-type="edited-by" id="fn0004">
<p>Reviewed by: Yuan Liu, Yangzhou University, China; Cong Shen, Guangzhou University of Chinese Medicine, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Jinbo Liu, <email>liujb7203@swmu.edu.cn</email></corresp>
<corresp id="c002">Zhangrui Zeng, <email>zengzhangrui@swmu.edu.cn</email></corresp>
<fn fn-type="equal" id="fn0002">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1207441</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Ding, Hao, Xiao, Ye, Xiao, Jian, Tang, Li, Liu and Zeng.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Ding, Hao, Xiao, Ye, Xiao, Jian, Tang, Li, Liu and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Colistin is highly promising against multidrug-resistant and extensively drug-resistant bacteria clinically. Bacteria are resistant to colistin mainly through <italic>mcr</italic> and chromosome-mediated lipopolysaccharide (LPS) synthesis-related locus variation. However, the current understanding cannot fully explain the resistance mechanism in <italic>mcr</italic>-negative colistin-resistant strains. Significantly, the contribution of efflux pumps to colistin resistance remains to be clarified. This review aims to discuss the contribution of efflux pumps and their related transcriptional regulators to colistin resistance in various bacteria and the reversal effect of efflux pump inhibitors on colistin resistance. Previous studies suggested a complex regulatory relationship between the efflux pumps and their transcriptional regulators and LPS synthesis, transport, and modification. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP), 1-(1-naphthylmethyl)-piperazine (NMP), and Phe-Arg-&#x03B2;-naphthylamide (PA&#x03B2;N) all achieved the reversal of colistin resistance, highlighting the role of efflux pumps in colistin resistance and their potential for adjuvant development. The contribution of the efflux pumps to colistin resistance might also be related to specific genetic backgrounds. They can participate in colistin tolerance and heterogeneous resistance to affect the treatment efficacy of colistin. These findings help understand the development of resistance in <italic>mcr</italic>-negative colistin-resistant strains.</p>
</abstract>
<kwd-group>
<kwd>efflux pump</kwd>
<kwd>colistin resistance</kwd>
<kwd>lipopolysaccharide</kwd>
<kwd>efflux pump inhibitors</kwd>
<kwd>collateral susceptibility</kwd>
<kwd>heteroresistance</kwd>
</kwd-group>
<contract-num rid="cn1">2020YFQ0045 and 2021YFS0329</contract-num>
<contract-num rid="cn2">2019ZQN017</contract-num>
<contract-sponsor id="cn1">Sichuan Science and Technology Program</contract-sponsor>
<contract-sponsor id="cn2">School-level scientific research project of Southwest Medical University</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="142"/>
<page-count count="13"/>
<word-count count="12160"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>The emergence and widespread occurrence of carbapenem-resistant gram-negative bacteria (CRGB: <italic>Enterobacteriaceae</italic>, <italic>Pseudomonas</italic> spp., <italic>Acinetobacter</italic> spp., etc.) poses a severe public health risk, with some metallo-&#x03B2;-lactamases-producing individuals also revealing inherent resistance to ceftazidime/avibactam. These CRGB acquire multiple antimicrobial resistance determinants under the action of mobile elements, promoting their resistance to tetracycline, quinolone, aminoglycosides, and other antibiotics. Additionally, energy-dependent efflux pumps, the classical pathway of bacterial resistance, play an essential role in multidrug resistance in bacteria. The efflux pumps can be divided into resistance-nodulation-cell division (RND), major facilitator superfamily (MFS), multidrug and toxic compound extrusion (MATE), small multidrug resistance (SMR), and ATP-binding cassette (ABC) super-families based on the differences in efflux transport proteins (<xref ref-type="bibr" rid="ref60">Li and Nikaido, 2009</xref>). These transporters have a wide range of efflux substrates covering antibiotics for common clinical anti-infective treatments (&#x03B2;-lactams, tetracyclines, chloramphenicol, fluoroquinolones, aminoglycosides, sulfonamides, etc.), besides being involved in the elimination of bacterial intracellular metabolites. In the clinical infection setting, these efflux pumps also eliminate a wide range of chemical disinfectants favoring the long-term colonization of an abiotic surface by pathogens. These efflux pumps also respond quickly to enhance their viability when exposed to harsh environments (<xref ref-type="bibr" rid="ref27">Fern&#x00E1;ndez and Hancock, 2012</xref>). In particular, efflux pump transcription regulators are essential in regulating oxidative stress, physiological metabolism, and fitness (<xref ref-type="bibr" rid="ref43">Holden and Webber, 2020</xref>). These results suggest that the efflux pumps are also an efficient means for bacteria to resist external environmental stress. Understanding their operation and development can help understand the evolutionary process of bacteria.</p>
<p>As carbapenems failed to treat CRGB, colistin (polymyxin B and E) was reintroduced to treat some refractory gram-negative infections. Colistin, as a cationic polypeptide compound, mainly acts on the outer membrane of bacteria carrying a negative charge. Colistin can destroy the stability of the outer membrane by displacing Ca<sup>2+</sup> and Mg<sup>2+</sup> ions, thus playing a bactericidal role (<xref ref-type="bibr" rid="ref23">Falagas and Kasiakou, 2005</xref>). However, the lipid modification mediated by mutation and the inactivation of the two-component regulatory systems (TCS: PmrAB and PhoPQ) and <italic>mgrB</italic> are common causes of reduced susceptibility to colistin in bacteria. Plasmid-mediated horizontal transfer of <italic>mcr</italic> and its variants in bacteria promotes the rapid emergence of colistin resistance. In contrast, the role of efflux pumps in colistin resistance has received less attention. Previous studies have shown that efflux pump inhibitors (EPIs) CCCP and NMPs reverse colistin resistance, suggesting the role of efflux pumps in colistin resistance. Despite colistin&#x2019;s much larger size than other common antibiotics and chemicals, the efflux of colistin compounds may be used as efflux substrates have been observed in many bacteria (<xref ref-type="bibr" rid="ref125">Warner and Levy, 2010</xref>; <xref ref-type="bibr" rid="ref116">Sundaramoorthy et al., 2019a</xref>). LPS modification and overexpression of efflux pumps and their regulators are also thought to be important components of the colistin resistance mechanisms in mcr-negative <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="ref83">Naha et al., 2022</xref>). In January 2023, we conducted a search on PubMed and Web of Science databases using keywords such as &#x201C;colistin,&#x201D; &#x201C;efflux pump,&#x201D; and &#x201C;cationic antimicrobial peptide.&#x201D; We screened over 100 publications summarized in this review, aiming to explore the role of the efflux pump in colistin resistance and provide a basis for elucidating the resistance mechanisms of mcr-negative colistin-resistant strains. The flow chart depicting the search and selection process is provided in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>.</p>
</sec>
<sec id="sec2">
<title>General and novel colistin resistance mechanisms</title>
<p>The absence of the outer membrane limits the use of colistin against gram-positive bacteria. The colistin resistance mechanisms in gram-negative bacteria have been summarized in many previous reviews (<xref ref-type="bibr" rid="ref46">Jeannot et al., 2017</xref>; <xref ref-type="bibr" rid="ref32">Gogry et al., 2021</xref>). In general, the colistin resistance mechanism mainly includes two steps. First, point mutations in the TCS PmrAB, PhoPQ, CrrAB, and other lipid A modification coding genes located in chromosome loci produce more positively charged phosphoethanolamine to be added to the outer membrane lipids, resulting in weakened binding to colistin. Mutational inactivation and truncation of the insertion sequence of the PhoQ kinase inhibitor <italic>mgrB</italic> may also be effectively involved in this process. Second, phosphoethanolamine transferase encoded by <italic>mcr</italic> can also mediate the modification of the outer membrane (lipid A). More than 100 variants of <italic>mcr</italic> have been identified since it was first reported in 2015 (<xref ref-type="bibr" rid="ref0001">Liu et al., 2016</xref>).<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> The <italic>mcr</italic> variants have completed horizontal transfer among different species with the help of mobile elements, posing a severe threat to public health. Compensatory mutations can effectively alleviate the fitness costs of <italic>mcr</italic> and promote the continued existence of plasmids carrying <italic>mcr</italic> (<xref ref-type="bibr" rid="ref127">Yang et al., 2020</xref>). A recent study on <italic>A. hydrophila</italic> suggests that MlaA, the outer membrane lipoprotein-encoding gene, may be associated with high levels of colistin resistance (<xref ref-type="bibr" rid="ref67">Liu et al., 2021</xref>). A recent study found that the RpoE stress system mediated colistin resistance in <italic>E. coli</italic> without disturbing the lipid A profile (<xref ref-type="bibr" rid="ref133">Zeng et al., 2023</xref>). The discovery of colistin-degrading proteases also reveals the diversity of colistin resistance mechanisms (<xref ref-type="bibr" rid="ref54">Lee et al., 2022</xref>).</p>
</sec>
<sec id="sec3">
<title>Impacts of EPIs on colistin resistance</title>
<p>Although colistin is one of the few treatments available for multi-drug resistant pathogens, it does not seem effective in reducing patient mortality (<xref ref-type="bibr" rid="ref001">Kelesidis and Falagas, 2015</xref>; <xref ref-type="bibr" rid="ref56">Lee et al., 2020</xref>). Therefore, effective alternative treatment measures need to be developed. Current reviews of colistin resistance mechanisms have described less about the contribution of efflux pumps. <xref ref-type="bibr" rid="ref85">Ni et al. (2016)</xref> successfully restored colistin susceptibility in colistin-resistant <italic>A. baumannii</italic>, <italic>P. aeruginosa</italic>, <italic>K. pneumoniae</italic>, and <italic>S. maltophilia</italic> using the efflux pump inhibitor CCCP (<xref rid="tab1" ref-type="table">Table 1</xref>). Subsequent studies demonstrated that CCCP reversed colistin resistance in gram-negative bacteria that produced or did not produce <italic>mcr</italic> (<xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako, 2017</xref>; <xref ref-type="bibr" rid="ref4">Baron and Rolain, 2018</xref>). In contrast, other common EPIs (reserpine, verapamil, PA&#x03B2;N, and NMP) have more pronounced effects on the MICs of non-colistin-resistant strains (<xref rid="tab1" ref-type="table">Table 1</xref>) (<xref ref-type="bibr" rid="ref85">Ni et al., 2016</xref>; <xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako, 2017</xref>). DNP, another proton-carrier inhibitor similar to CCCP, has apparent effects on colistin-resistant <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="ref96">Park and Ko, 2015</xref>). These results suggested that the differences in EPIs might be the main reason influencing the restoration of colistin susceptibility. The possible explanation is that CCCP-mediated electrochemical gradient depolarization can restore the negative charge of the outer membrane and lead to increased susceptibility to bacteria (<xref ref-type="bibr" rid="ref85">Ni et al., 2016</xref>). Similarly, the MarR inhibitor salicylic acid can affect the negative cell surface charge of colistin-resistant <italic>E. coli</italic> and restore colistin susceptibility, but this effect is not apparent in colistin-sensitive <italic>E. coli</italic> (<xref ref-type="bibr" rid="ref117">Sundaramoorthy et al., 2019b</xref>). Meanwhile, CCCP can reduce the metabolic activity of <italic>A. baumannii</italic> and increase its susceptibility to colistin (<xref ref-type="bibr" rid="ref96">Park and Ko, 2015</xref>). A study in <italic>P. aeruginosa</italic> also showed that CCCP affected energy metabolism and thus decreased the colistin tolerance of <italic>P. aeruginosa</italic> biofilms (<xref ref-type="bibr" rid="ref94">Pamp et al., 2008</xref>). In contrast, a previous study showed that CCCP contributed to the increase in polymyxin B resistance in wild-type and <italic>phop</italic> mutant in survival assays, which was mainly explained by the reduction of the proton gradient in the bacterial inner membrane (<xref ref-type="bibr" rid="ref1">Alteri et al., 2011</xref>). Overall, more evidence is needed to confirm its impact on the cellular microenvironment and the potential involvement of other mechanisms.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Effect of common efflux pump inhibitors on the colistin MICs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Isolate</th>
<th align="center" valign="middle" rowspan="2"><italic>mcr</italic></th>
<th align="center" valign="middle" colspan="4">Efflux pump inhibitors</th>
<th align="center" valign="middle" colspan="2">FC</th>
<th align="left" valign="middle" rowspan="2">References</th>
</tr>
<tr>
<th align="center" valign="middle">CCCP</th>
<th align="center" valign="middle">NMP</th>
<th align="center" valign="middle">PA&#x03B2;N</th>
<th align="center" valign="middle">other</th>
<th align="center" valign="middle">&#x2265;4</th>
<th align="center" valign="middle">2</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>E. coli</italic></td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref62">Liao et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>E. coli</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>K. pneumoniae</italic></td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>K. pneumoniae</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>K. pneumoniae</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref115">Sun L. et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>K. pneumoniae</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref84">Naha et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>A. baumannii</italic></td>
<td align="center" valign="top">Unknown</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref85">Ni et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>A. baumannii</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">TZ, CPZ</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref73">Machado et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>A. baumannii</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref129">Yilmaz et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>A. baumannii</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">DNP</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref96">Park and Ko (2015)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>P. aeruginosa</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>P. aeruginosa</italic></td>
<td align="center" valign="top">Unknown</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref85">Ni et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>S. marcescens</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>S. maltophilia</italic></td>
<td align="center" valign="top">Unknown</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref85">Ni et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>S. maltophilia</italic></td>
<td align="center" valign="top">Unknown</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref85">Ni et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>E. cloacae</italic></td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>E. cloacae</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>E. cloacae&#x002A;</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref119">Telke et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>C. freundii</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref91">Osei Sekyere and Amoako (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>S. enterica</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>M. morganii</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>P. mirabilis</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref4">Baron and Rolain (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>A. hydrophila</italic></td>
<td align="center" valign="top">Unknown</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref68">Lo et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>B. intermedia</italic></td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="center" valign="top">&#x25A0;</td>
<td align="center" valign="top">&#x00D7;</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref140">Zoaiter et al. (2023)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>TZ, thioridazine; CPZ, chlorpromazine; DNP, 2,4-dinitrophenol; FC, Fold change; &#x002A;<italic>E. cloacae/E. asburiae</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Efflux pumps belonging to RND, MATE, SMR, and MFS families can use proton motive force to mediate efflux to various antibiotics (<xref ref-type="bibr" rid="ref69">Lomovskaya and Watkins, 2001</xref>). Notably, CCCP reduces the activity of these multidrug-resistant efflux pumps by disrupting the proton motive force through interference with the transmembrane potential. A recent study found that CCCP, but not PA&#x03B2;N, reversed colistin resistance in a colistin-resistant <italic>K. pneumoniae</italic> strain that was <italic>mcr</italic>-negative and had no mutations in <italic>mgrB</italic>, <italic>phoPQ</italic>, <italic>pmrABCDK</italic> and reported efflux pump-related genes (<italic>ramAR</italic>, <italic>acrAB</italic>, <italic>kpnEF</italic>/GH, <italic>soxS</italic>, etc.) (<xref ref-type="bibr" rid="ref102">Pu et al., 2023</xref>). It remains unclear whether other proton motive force-dependent and energy-driven efflux pumps contribute to colistin resistance (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Additionally, the <italic>crrB</italic> mutant <italic>K. pneumoniae</italic> had a 4-fold decreased for colistin MIC in the presence of PA&#x03B2;N, suggesting a potential role of the efflux pump in colistin resistance (<xref ref-type="bibr" rid="ref115">Sun L. et al., 2020</xref>). In the presence of NMP, the colistin MICs in colistin-resistant with <italic>mcr</italic>-negative <italic>A. baumannii</italic>/K have been observed<italic>. Pneumoniae</italic> lacking lipid A-related modification gene variation decreased significantly (<xref ref-type="bibr" rid="ref84">Naha et al., 2020</xref>; <xref ref-type="bibr" rid="ref129">Yilmaz et al., 2020</xref>). Li et al. also found that the colistin MICs in ST11-<italic>bla</italic><sub>KPC-2</sub> resistant lineage significantly reduced in the presence of NMP (<xref ref-type="bibr" rid="ref128">Yang et al., 2021</xref>). Although these results suggest a potential pathway for the involvement of efflux pumps in colistin resistance, more substantial evidence is still needed. Considering the differences among species, we then summarized in detail the roles of the efflux pumps and their related genes in colistin resistance in different species.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Potential relationship between multidrug resistance efflux pumps and their transcriptional regulatory factors and colistin resistance (<italic>E.coli</italic>, <italic>Enterobacter</italic>, and <italic>Salmonella</italic>). Two-component regulatory systems (PmrAB, PhoPQ, etc.) and related pathway variations are the classical pathways of <italic>mcr</italic>-negative colistin-resistant isolates. (1) Derepressed <italic>marA/soxS</italic> activated AcrAB-TolC or other RND efflux pumps involved in antibiotics efflux. (2) <italic>marA</italic> overexpression conferred collateral sensitivity to cationic antimicrobial peptides by up-regulating <italic>waaY</italic>. (3) Role of <italic>tolC</italic> in regulating PhoPQ via <italic>ecr</italic> in <italic>Enterobacter</italic> spp. remains to be confirmed. (4) Whether the effect of CCCP on the bacterial microenvironment mediates the change in colistin susceptibility is unclear.</p>
</caption>
<graphic xlink:href="fmicb-14-1207441-g001.tif"/>
</fig>
</sec>
<sec id="sec4">
<title>Enterobacteriaceae</title>
<sec id="sec5">
<title><italic>Escherichia coli</italic>, <italic>Enterobacter</italic>, and <italic>Salmonella</italic></title>
<p>Colistin-resistant Enterobacteriaceae are widely identified in clinical infection settings and animal husbandry, and the status of antimicrobial resistance is a concern (<xref ref-type="bibr" rid="ref002">Shen et al., 2019</xref>). As a transcription regulator commonly found in <italic>E. coli</italic>, <italic>K. pneumoniae</italic>, and other members of Enterobacteriaceae, <italic>marR</italic> played an essential role in regulating efflux pumps. Furthermore, <italic>marR</italic> mediated the inhibition of <italic>marA</italic>, while salicylic acid, antibiotic pressure, and endogenous amino acid replacement could release the disinhibition and activate <italic>marA</italic> expression under physiological conditions, thus upregulating the MDR efflux pump AcrAB-TolC (<xref ref-type="bibr" rid="ref35">Grkovic et al., 2002</xref>). Activated <italic>marA</italic> could also upregulate the expression of gene encoding lipopolysaccharide core heptose (II) kinase, known as <italic>waay</italic>. This upregulation increases the negative charge of the bacterial outer membrane, subsequently enhancing its ability to bind cationic antimicrobial peptides (collateral sensitivity) (<xref ref-type="bibr" rid="ref53">L&#x00E1;z&#x00E1;r et al., 2018</xref>). <xref ref-type="bibr" rid="ref117">Sundaramoorthy et al. (2019b)</xref> found that the negative charge of the outer membrane of colistin-resistant <italic>E. coli</italic> increased in the presence of the <italic>marR</italic> inhibitor salicylic acid, thereby restoring susceptibility to colistin. Another study found that the decreased polymyxin B susceptibility due to the <italic>marAB</italic> upregulation and <italic>marR</italic> mutant was observed, mainly attributed to the action of AcrAB and other TolC-dependent efflux pumps (<xref ref-type="bibr" rid="ref125">Warner and Levy, 2010</xref>). These findings demonstrated the different pathways through which <italic>marRA</italic> is involved in colistin resistance. Another <italic>soxRS</italic> system, common in <italic>E. coli</italic> and <italic>Salmonella</italic>, plays an essential role in coping with superoxide, nitric oxide, and antibiotic stress. Increased <italic>soxS</italic> expression induced multidrug-resistant efflux pump AcrAB expression, decreased membrane permeability, and promoted the formation of multidrug-resistant phenotypes (<xref ref-type="bibr" rid="ref51">Koutsolioutsou et al., 2005</xref>). The same binding sites exist in the promoters regulating Sox, Rob, and Mar systems (<italic>mar</italic>/<italic>sox</italic> box), resulting in a high degree of overlap between the genes (<italic>micF</italic>, <italic>acrAB</italic>, <italic>ompF</italic>, <italic>fumC</italic>, etc.) of <italic>soxRS</italic> and <italic>mar</italic> regulons (<xref rid="fig1" ref-type="fig">Figure 1</xref>) (<xref ref-type="bibr" rid="ref75">Martin et al., 1999</xref>). Both <italic>soxRS</italic> and <italic>waaY</italic> could be activated by superoxide induction, but <italic>waaY</italic> transcription was <italic>SoxRS</italic> dependent (<xref rid="fig1" ref-type="fig">Figure 1</xref>) (<xref ref-type="bibr" rid="ref55">Lee et al., 2009</xref>). Although the absence or overexpression of <italic>soxS</italic> in <italic>E. coli</italic> harboring the <italic>soxR</italic> mutation did not significantly affect CAMP susceptibility, the overexpression of <italic>SoxS</italic> in the <italic>tolC</italic> mutant contributed to increased susceptibility to polymyxin B (<xref ref-type="bibr" rid="ref125">Warner and Levy, 2010</xref>). A recent study showed that not only the collateral susceptibility of antimicrobial resistance development to cationic polypeptides was associated with the changes in the regulation of LPS-related genes, but also a variety of physiological metabolism-related genes such as iron ion-binding proteins and transmembrane transport proteins played an important role (<xref ref-type="bibr" rid="ref34">Gr&#x00E9;zal et al., 2023</xref>). This also reflected the pleiotropy of these global regulators involved in regulating multiple links of physiological metabolism. The disruption of <italic>tolC</italic> directly affected outer membrane integrity, and the intracellular accumulation of toxic substances activated <italic>marA</italic>, <italic>soxS</italic>, and <italic>rob</italic> to upregulate the efflux pumps (<xref ref-type="bibr" rid="ref108">Rosner and Martin, 2009</xref>; <xref ref-type="bibr" rid="ref134">Zgurskaya et al., 2011</xref>). Additionally, Rob might directly or indirectly increase <italic>marRAB</italic> expression by upregulating <italic>micF</italic> in response to colistin pressure, although the <italic>rob</italic> deficiency had little effect on CAMP susceptibility (<xref ref-type="bibr" rid="ref89">Oh et al., 2000</xref>; <xref ref-type="bibr" rid="ref125">Warner and Levy, 2010</xref>).</p>
<p>Heteroresistance may be an intermediate stage in the transition of susceptible bacteria to antimicrobial resistance, which is an essential reason for the failure of clinical anti-infective therapy (<xref ref-type="bibr" rid="ref24">Falagas et al., 2008</xref>). Telke et al. found that <italic>soxRS</italic>-induced AcrAB-TolC efflux pump mediated heterogeneous resistance to colistin and could restore colistin susceptibility through PA&#x03B2;N in <italic>Enterobacter</italic> spp. (<xref ref-type="bibr" rid="ref119">Telke et al., 2017</xref>). Unlike CCCP and DNP, PA&#x03B2;N could act directly as an inhibitor of AcrAB and AcrEF efflux pumps. Therefore, these results also suggested that AcrAB efflux pump was involved in colistin resistance (<xref ref-type="bibr" rid="ref77">Misra et al., 2015</xref>). Colistin could mediate bactericidal effects by producing hydroxyl radicals or causing oxidative stress reactions as a class of bactericidal antibiotics (<xref ref-type="bibr" rid="ref9">Bialvaei and Samadi Kafil, 2015</xref>; <xref ref-type="bibr" rid="ref132">Yu et al., 2019</xref>). However, this bactericidal effect did not appear to influence the <italic>soxRS</italic> transcriptional levels in heterogeneous colistin-resistant <italic>Enterobacter</italic> isolates (<xref ref-type="bibr" rid="ref119">Telke et al., 2017</xref>). The necessity of colistin heteroresistance by <italic>tolC</italic> (but not <italic>acrB</italic>) was further confirmed in <italic>E. cloacae</italic>, and <italic>tolC</italic> could activate the PhoQ-PhoP system by affecting the <italic>ecr</italic> (<xref rid="fig1" ref-type="fig">Figure 1</xref>) (<xref ref-type="bibr" rid="ref45">Huang et al., 2019</xref>). The deletion of <italic>acrB</italic> is not sufficient to completely reverse colistin heterologous resistance in <italic>E. cloacae</italic> (<xref ref-type="bibr" rid="ref45">Huang et al., 2019</xref>). Previous findings suggested efflux pumps are the primary mechanism for generating stable heterogeneous subpopulations (<xref ref-type="bibr" rid="ref74">Manjunath et al., 2021</xref>). The fitness costs of these resistance mechanisms remain to be evaluated. Besides the co-regulation of <italic>tolC</italic> with Mar, Rob, and Sox, the expression of <italic>tolC</italic>, which carried multiple promoters, was also affected by EvgAS and PhoPQ, indicating that AcrAB-TolC had the potential to cope with different environments and responded quickly (<xref ref-type="bibr" rid="ref136">Zhang et al., 2008</xref>; <xref ref-type="bibr" rid="ref99">P&#x00E9;rez et al., 2012</xref>).</p>
<p>Transcriptome and proteomics analyses revealed that the expression of efflux pump AcrAB in <italic>E. coli</italic> and <italic>K. pneumoniae</italic> significantly increased after exposure to polymyxin B under experimental conditions (<xref ref-type="bibr" rid="ref106">Ramos et al., 2016</xref>; <xref ref-type="bibr" rid="ref66">Liu et al., 2020</xref>). The overexpression of <italic>cpxR</italic> in the absence of <italic>acrB</italic> affected the expression of TCS genes (<italic>phoP</italic>, <italic>phoQ</italic>, <italic>pmrB</italic>, <italic>pmrC</italic>, <italic>pmrH</italic>, and <italic>pmrD</italic>) and restored colistin susceptibility in <italic>Salmonella</italic> (<xref ref-type="bibr" rid="ref135">Zhai et al., 2018</xref>). The variation in the <italic>acrB</italic> 620 site in <italic>Salmonella</italic> contributed to the restoration of colistin susceptibility, which could be explained by the defective macromolecular transport due to the altered conformation of the switch loop in this site (<xref ref-type="bibr" rid="ref14">Cha et al., 2014</xref>; <xref ref-type="bibr" rid="ref48">Kapach et al., 2020</xref>). Either <italic>tolC</italic> deletion alone or dual deletion of <italic>cpxR</italic> and <italic>tolC</italic> increased the susceptibility of <italic>S. enterica</italic> to colistin to varying degrees. The inactivation of <italic>tolC</italic> impaired the function of the entire RND efflux family and other <italic>tolC</italic>-dependent efflux pumps, not only the AcrAB pump (<xref ref-type="bibr" rid="ref138">Zhang M. K. et al., 2021</xref>). These results highlighted the different contributions of <italic>acrB</italic>, <italic>soxRS</italic>, and <italic>marRA</italic> to colistin resistance in different backgrounds, the role of <italic>tolC</italic> mutations in regulating colistin resistance, and the complex regulatory network among the efflux pump, two-component system, and LPS modification.</p>
</sec>
<sec id="sec6">
<title><italic>Klebsiella pneumoniae</italic></title>
<p>Multicenter studies from China have shown that the insertion inactivation of <italic>mgrB</italic> is the primary mechanism of colistin resistance in <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="ref59">Li et al., 2023</xref>). However, <italic>acrR</italic> insertion by IS<italic>26</italic> is widespread in ST11-<italic>bla</italic><sub>KPC-2</sub>-producing PR-CRKP (Polymyxin-resistant carbapenem-resistant <italic>K. pneumonia</italic>), which may be related to the low level of colistin resistance in these high-risk clones (<xref ref-type="bibr" rid="ref128">Yang et al., 2021</xref>; <xref ref-type="bibr" rid="ref59">Li et al., 2023</xref>). <italic>ramRA</italic> is a widely described global regulator in <italic>K. pneumoniae</italic> compared with <italic>E. coli</italic> and <italic>Salmonella</italic>, which mediates resistance to antibiotics such as tigecycline, nitrofurantoin, and beta-lactams by regulating AcrAB and OqxAB (<xref ref-type="bibr" rid="ref36">Hao et al., 2022</xref>). The expression of <italic>soxS</italic>, <italic>ramA</italic>, and <italic>acrAB-tolC</italic> significantly upregulated in <italic>mcr</italic>-negative colistin-resistant <italic>K. pneumoniae</italic> lacking specific TCS-related gene variants, suggesting the role of <italic>soxS</italic>, <italic>ramA</italic>, and efflux pumps in colistin resistance (<xref ref-type="bibr" rid="ref84">Naha et al., 2020</xref>). Similar to <italic>marA</italic> and <italic>soxS</italic>, <italic>ramA</italic> can also affect LPS modification. <italic>ramA</italic> directly binds to and activates the genes involved in lipid A biosynthesis: <italic>lpxC</italic>, <italic>lpxL</italic>-2, and <italic>lpxO</italic>, thereby modifying lipid A and resulting in decreased colistin susceptibility and increased anti-serum phagocytosis under the condition of increased <italic>ramA</italic> expression (<xref rid="fig2" ref-type="fig">Figure 2</xref>) (<xref ref-type="bibr" rid="ref21">De Majumdar et al., 2015</xref>). Li et al. demonstrated <italic>in vitro</italic> that <italic>ramR</italic> variants can mediate polymyxin resistance, possibly related to derepressed <italic>ramA</italic>-mediated LPS alterations and multidrug resistance efflux pump overexpression (AcrAB) (<xref ref-type="bibr" rid="ref59">Li et al., 2023</xref>). Another survey in China showed that the transcription level of <italic>ramA</italic> in colistin-resistant <italic>K. pneumoniae</italic> was not statistically significantly different from that in non-colistin-resistant strains, but the study lacked the main antimicrobial resistant and hypervirulent lineages ST11 and ST23 prevalent in China (<xref ref-type="bibr" rid="ref124">Wang et al., 2017</xref>). However, <italic>ramA</italic> overexpression and variation were common in some colistin-resistant <italic>K. pneumoniae</italic> ST11 and ST147 isolates (<xref ref-type="bibr" rid="ref84">Naha et al., 2020</xref>; <xref ref-type="bibr" rid="ref72">Lv et al., 2021</xref>; <xref ref-type="bibr" rid="ref11">Bolourchi et al., 2021a</xref>,<xref ref-type="bibr" rid="ref12">b</xref>). Cationic antimicrobial peptides are also common in the human environment. Thus, whether these high-risk clones contribute to the co-evolution of hypervirulence and antimicrobial resistance by activating the efflux pump is not clear. A previous study showed that &#x0394;<italic>acrB K. pneumoniae</italic> mutant had increased susceptibility to colistin and that LPS and CPS production were not significantly affected, revealing a role for AcrAB in the antimicrobial peptides resistance (<xref ref-type="bibr" rid="ref93">Padilla et al., 2010</xref>). A less-described class of multidrug efflux RND transporter, KexD, is also present in <italic>K. pneumoniae</italic> and can be expressed constitutively with <italic>E. coli</italic> TolC or <italic>K. pneumoniae</italic> KocC (<xref ref-type="bibr" rid="ref88">Ogawa et al., 2012</xref>). <italic>KexD</italic> has been proven to contribute to colistin resistance, and both of them are more conducive to high-level colistin resistance in <italic>K. pneumoniae</italic> under the induction of its neighbor gene <italic>crrB</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>) (<xref ref-type="bibr" rid="ref18">Cheng et al., 2018</xref>; <xref ref-type="bibr" rid="ref95">Pantel et al., 2023</xref>). The specific diversity of the <italic>crrBAC</italic>-<italic>kexD</italic> cluster in the <italic>K. pneumoniae</italic> ST11 group suggests that ST11, a closely related lineage with carbapenem resistance and hypervirulence, is at risk of further developing colistin resistance (<xref ref-type="bibr" rid="ref49">Kim et al., 2022</xref>). Overall, the colistin resistance mechanisms in <italic>mcr-</italic>negative colistin-resistant pathogens may be accumulated, highlighting the synergistic involvement of multiple mechanisms. Notably, the homolog of <italic>mexCD</italic>-<italic>oprJ</italic> efflux, <italic>tmexCD</italic>-<italic>toprJ</italic>, can be plasmid-mediated to acquire resistance to tigecycline in <italic>Enterobacteriaceae</italic> rapidly (<xref ref-type="bibr" rid="ref004">Lv et al., 2020</xref>). In recent years, it has been identified that <italic>tmexCD-toprJ</italic> and <italic>mcr</italic> coexist in the same host of mobile elements, declaring the failure of last-line antibiotics (tigecycline and colistin) treatment and suggesting the threat of the rapid emergence of superbugs (<xref ref-type="bibr" rid="ref114">Sun S. et al., 2020</xref>; <xref ref-type="bibr" rid="ref22">Dong et al., 2022</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Potential relationship between multidrug resistance efflux pumps and their transcriptional regulatory factors and colistin resistance (<italic>K. pneumoniae</italic>). (1) <italic>ramAR</italic> was the dominant efflux pump transcriptional regulator in <italic>K. pneumoniae</italic>, binding to <italic>lpxC/X/O</italic> and participating in lipopolysaccharide synthesis. (2) KpnEF efflux pump was regulated by <italic>cpxRA</italic> and involved in colistin efflux and capsule synthesis. (3) Co-expression of CrrAB with the adjacent KexD efflux pump promoted the development of high levels of colistin resistance.</p>
</caption>
<graphic xlink:href="fmicb-14-1207441-g002.tif"/>
</fig>
<p>A study showed that several <italic>mcr</italic>-negative colistin-resistant <italic>K. pneumoniae</italic> strains isolated from CC15 and CC101 had different degrees of overexpression of <italic>acrAB</italic>, <italic>ramA</italic>, <italic>kpnEF</italic> (SMR pump), and <italic>kpnGH</italic> (MFS pump) (<xref ref-type="bibr" rid="ref83">Naha et al., 2022</xref>). <italic>KpnEF</italic> efflux pumps belong to the small MDR family. The <italic>&#x0394;</italic>KpnEF mutants showed increased susceptibility to various cationic antimicrobial peptides such as colistin, whereas <italic>KpnEF</italic> expression differs in the <italic>cpxAR</italic> mutant background (<xref rid="fig2" ref-type="fig">Figure 2</xref>) (<xref ref-type="bibr" rid="ref112">Srinivasan and Rajamohan, 2013</xref>). The <italic>kpnGH</italic> is homologous to <italic>emrAB</italic> and belongs to the MFS efflux pump. <italic>In vitro</italic>, <italic>&#x0394;</italic>kpnGH mutant susceptibility to cephalosporins, imipenem, polymyxin B, chlorhexidine, and other antimicrobial agents increased (<xref ref-type="bibr" rid="ref113">Srinivasan et al., 2014</xref>).</p>
</sec>
<sec id="sec7">
<title><italic>Acinetobacter baumannii</italic></title>
<p>The antimicrobial resistance surveillance from China showed that the colistin resistance rate of <italic>A. baumannii</italic> was still relatively low, but more than half of the isolates showed carbapenem-resistant <italic>A. baumannii</italic> (CRAB) (<xref ref-type="bibr" rid="ref29">Gao et al., 2017</xref>; <xref ref-type="bibr" rid="ref139">Zhang et al., 2020</xref>). <italic>A. baumannii</italic> had intrinsic resistance to multiple antibiotics. Hence, colistin has become one of the few options for treating CRAB. In the clinical application of colistin in anti-infection therapy, it is easy to induce <italic>A. baumannii</italic> to lead to colistin resistance by modifying phosphoethanolamine mediated by the two-component regulatory system PmrAB (<xref ref-type="bibr" rid="ref105">Qureshi et al., 2015</xref>). In <italic>A. baumannii</italic>, three significant efflux pumps, AdeAB, AdeIJK, and AdeFGH, are involved in expelling antibiotics such as tetracycline, beta-lactam, and quinolones (<xref ref-type="bibr" rid="ref3">Ayoub Moubareck and Hammoudi Halat, 2020</xref>). After <italic>A. baumannii</italic> was exposed to colistin, the upregulation of Ade cluster encoding genes was common; <italic>emrB</italic> and <italic>macAB</italic> overexpression were also observed (<xref ref-type="bibr" rid="ref16">Cheah et al., 2016</xref>; <xref ref-type="bibr" rid="ref44">Hua et al., 2017</xref>; <xref ref-type="bibr" rid="ref10">Boinett et al., 2019</xref>). In <italic>E. coli</italic>, MacA demonstrated high affinity and specificity for the core LPS, suggesting that MacAB-TolC could be involved in LPS transport (<xref ref-type="bibr" rid="ref71">Lu and Zgurskaya, 2013</xref>). <italic>phoP</italic> inhibited <italic>macAB</italic> transcription, and <italic>macAB</italic> deletion attenuated <italic>Salmonella</italic>&#x2019;s virulence more than the <italic>tolC</italic> mutant (<xref ref-type="bibr" rid="ref86">Nishino et al., 2006</xref>). Despite the upregulation of MDR efflux pumps, the laboratory-induced colistin-resistant isolates showed restoration of susceptibility to cefepime, azithromycin, and teicoplanin compared with the parental isolates (<xref ref-type="bibr" rid="ref80">Moffatt et al., 2010</xref>; <xref ref-type="bibr" rid="ref61">Li et al., 2015</xref>). Hua et al. also found that colistin induced partial restoration of antibiotic susceptibility in resistant strains but they mainly focused on &#x03B2;-lactams (<xref ref-type="bibr" rid="ref44">Hua et al., 2017</xref>). Increased susceptibility to bacitracin, vancomycin, and beta-lactams was also observed in <italic>A. baumannii</italic> with high permeability of the outer membrane (<xref ref-type="bibr" rid="ref57">Leus et al., 2018</xref>). These phenomena suggested that efflux pumps might be more involved in the transport of toxic compounds rather than in the efflux of the dominant antibiotics in colistin-resistant strains with increased outer membrane permeability due to LPS loss (<xref ref-type="bibr" rid="ref41">Henry et al., 2012</xref>; <xref ref-type="bibr" rid="ref40">Henry et al., 2015</xref>). Such collateral sensitivity could be masked by multiple &#x03B2;-lactamases and other plasmid-mediated resistance determinants in some clinical isolates of colistin-resistant <italic>A. baumannii</italic>.</p>
<p><xref ref-type="bibr" rid="ref73">Machado et al. (2018)</xref> identified several heterogeneous colistin-resistant strains that lacked TCS gene variants (<italic>lpxACD</italic> and <italic>pmrCAB</italic>). The EPIs CCCP, NMP, and PA&#x03B2;B were found to reverse polymyxin resistance to varying degrees in these strains. Furthermore, these strains&#x2019; efflux pump genes <italic>adeB</italic>, <italic>adeJ</italic>, <italic>adeG</italic>, <italic>craA</italic>, <italic>amvA</italic>, <italic>abeS</italic>, and <italic>abeM</italic> were overexpressed after colistin exposure (<xref ref-type="bibr" rid="ref73">Machado et al., 2018</xref>). Colistin resistance mediated by the mutations in the <italic>pmr</italic> operon is generally expensive for <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="ref30">Geisinger and Isberg, 2017</xref>). Colistin heteroresistant <italic>A. baumannii</italic> isolates with only <italic>lpxACD</italic> mutations and overexpression of <italic>adeAB</italic>, <italic>adeG</italic>, and <italic>adeIJK</italic> were also observed in other studies, highlighting the role of efflux pumps in colistin heteroresistance (<xref ref-type="bibr" rid="ref17">Chen et al., 2020</xref>). Besides participating in antibiotics efflux, the overexpression of these efflux pumps may be associated with fitness advantages mediated by these clinical isolates at specific sites of infection (<xref ref-type="bibr" rid="ref130">Yoon et al., 2016</xref>). Another study also demonstrated that the resistance of <italic>A. baumannii</italic> to colistin could be reversed by NMP. AdeRS mutations mediating AdeAB or other RND-type efflux system overexpression were suggested to be the possible cause of colistin resistance in these isolates (<xref ref-type="bibr" rid="ref129">Yilmaz et al., 2020</xref>). Additionally, increased expression of efflux transporter proteins (AdeABC and HlyD family) after colistin exposure was also observed in another study (<xref ref-type="bibr" rid="ref16">Cheah et al., 2016</xref>). However, neither AdeRS nor AdeAB was shown to affect the colistin MIC <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref107">Richmond et al., 2016</xref>). These findings also suggested that efflux pump overexpression played a role in the excretion of toxic compounds and maintaining outer membrane integrity besides antibiotic efflux. The role of efflux pumps in antimicrobial resistance is also influenced by specific physiological settings (<xref ref-type="bibr" rid="ref57">Leus et al., 2018</xref>). Additionally, different biological effects were found in AdeB deletion strains with different genetic backgrounds, suggesting that the function of the AdeAB efflux pump might be heterogeneous in other individuals (<xref ref-type="bibr" rid="ref107">Richmond et al., 2016</xref>). These results indicated that the AdeAB pump could target different substrates under different living environments and selective pressures.</p>
<p>The two-component system and efflux pumps can be activated in bacteria by pH, nutrients, redox state, osmotic pressure, quorum signaling, and antibiotics (<xref ref-type="bibr" rid="ref126">Worthington et al., 2013</xref>; <xref ref-type="bibr" rid="ref5">Bazyleu and Kumar, 2014</xref>). One reported that the expression of AdeRS, AdeABC, and AdeFGH promoters did not show significant differences under sub-MIC colistin concentration and different growth conditions (<xref ref-type="bibr" rid="ref31">Gil et al., 2021</xref>). However, the activation of the efflux pumps <italic>adeB</italic>, <italic>adeG</italic>, <italic>adeJ</italic>, <italic>adeH</italic>, and autoinducer synthase (<italic>abaI</italic>) by subinhibitory colistin has been observed in some clinical isolates (<xref ref-type="bibr" rid="ref109">Sato et al., 2018</xref>; <xref ref-type="bibr" rid="ref110">Shenkutie et al., 2022</xref>). Multiple biological effects on bacteria are observed at sublethal antibiotic concentrations, one of which can directly engage or interfere with quorum sensing systems (QS) (<xref rid="fig3" ref-type="fig">Figure 3</xref>) (<xref ref-type="bibr" rid="ref2">Andersson and Hughes, 2014</xref>). As a signal molecule in the QS system, <italic>abaI</italic> is essential in regulating biofilms and can be used as a substrate for the AdeFGH efflux pump (<xref ref-type="bibr" rid="ref38">He et al., 2015</xref>). <italic>A. baumannii</italic> isolates in a biofilm state has higher minimal biofilm inhibition concentrations (MBICs), which helps reduce the therapeutic effect of colistin (<xref ref-type="bibr" rid="ref50">Kim et al., 2015</xref>). However, AdeRS did not always exist in <italic>A. baumannii</italic> isolates (<xref ref-type="bibr" rid="ref81">Monta&#x00F1;a et al., 2015</xref>). The restoration of colistin susceptibility by EPIs was observed in some colistin-resistant isolates without <italic>adeRS</italic>, suggesting the existence of other regulatory pathways and efflux pumps involved in colistin resistance (<xref ref-type="bibr" rid="ref129">Yilmaz et al., 2020</xref>). Lin et al. observed that the transcription of <italic>emrB</italic> and several <italic>emrB</italic>- like genes were upregulated in colistin resistance-induced <italic>A. baumannii</italic>. Furthermore, &#x0394;<italic>emrB</italic> mutants had increased susceptibility to colistin, demonstrating the contribution of the EmrAB pump to colistin resistance in <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="ref64">Lin et al., 2017</xref>). EmrAB was previously described mainly in <italic>E. coli</italic> and could mediate increased resistance to nalidixic acid, thiolactamycin, nitroquinoline, and hydrophobic proton uncouplers, with relatively little information available in <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="ref131">Yousefian et al., 2021</xref>). In another study, significant transcriptional changes were observed in the MATE (<italic>ydhE</italic>), MFS (<italic>mdfA</italic>), and SMR (<italic>ynfA</italic> and <italic>sugE</italic>) efflux pumps of colistin-resistant <italic>A. baumannii</italic> upon exposure to subinhibitory colistin concentrations (<xref ref-type="bibr" rid="ref97">Paul et al., 2020</xref>). The overexpression of the MATE family efflux pump and <italic>mdfA</italic> contributes to the efflux of cationic compounds, but their contribution to colistin resistance remains confirmed (<xref ref-type="bibr" rid="ref39">He et al., 2011</xref>; <xref ref-type="bibr" rid="ref61">Li et al., 2015</xref>). A putative solvent/toluene-tolerant efflux ABC transporter protein, Ttg2C, may be essential in high-level colistin resistance in <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="ref120">Thi Khanh Nhu et al., 2016</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Potential relationship between multidrug resistance efflux pumps and their transcriptional regulatory factors and colistin resistance (<italic>P. aeruginosa</italic> and <italic>A. baumannii</italic>). (1) AdeRS, <italic>merR</italic>, and <italic>parRS</italic> activated AdeAB, MexXY-OprM, and MexAB-OprM to efflux antibiotics, respectively. (2) Efflux pumps were involved in colistin tolerance by transporting signaling molecules to activate the quorum sensing system. (3) Some colistin-resistant <italic>A. baumannii</italic> strains with efflux pump overexpression exhibited increased susceptibility to multiple antibiotics, which is associated with the disruption of LPS.</p>
</caption>
<graphic xlink:href="fmicb-14-1207441-g003.tif"/>
</fig>
</sec>
<sec id="sec8">
<title><italic>Pseudomonas aeruginosa</italic></title>
<p><italic>Pseudomonas aeruginosa</italic> is a common pathogen causing burn infection and cystic fibrosis, exhibiting intrinsic resistance to different antibiotics. MexAB-OprM, MexXY-OprM, and MexCD-OprJ are widely described RND family efflux pumps in <italic>P. aeruginosa</italic> with various efflux substrates: &#x03B2;-lactams, aminoglycosides, quinolones, tetracyclines, tigecycline, macrolides, amphenicols, novobiocin, sulfonamides, and trimethoprim (<xref ref-type="bibr" rid="ref61">Li et al., 2015</xref>). MexXY is an induced efflux system, often characterized by concentration-dependent induction by ribosomal inhibitors (such as chloramphenicol, tetracyclines, macrolides, and aminoglycosides) (<xref ref-type="bibr" rid="ref47">Jeannot et al., 2005</xref>). However, the overexpression of MexXY under exposure to ribosome-targeting antimicrobial agents was inversely correlated with colistin susceptibility and accompanied by the downregulation of the <italic>arn</italic> operon (<xref ref-type="bibr" rid="ref101">Poole et al., 2015</xref>). Meanwhile, the heterogeneity of MexXY expression was observed in clinically isolated colistin-resistant <italic>P. aeruginosa</italic> isolates with different resistance levels, suggesting the possibility of intervention by other mechanisms (<xref ref-type="bibr" rid="ref33">Goli et al., 2016</xref>). In an experiment on chlorhexidine (cationic polypeptide compounds) induced resistance, several mutants with decreased colistin susceptibility were observed, and these mutants exhibited MexY overexpression. While adding chlorpromazine significantly reduced the chlorhexidine MICs in the resistant mutants (<xref ref-type="bibr" rid="ref118">Tag ElDein et al., 2021</xref>). Under colistin selective pressure, the two-component regulator ParR-ParS activated the <italic>arnBCADTEF</italic> operon, promoted <italic>mexY</italic> overexpression and inhibited <italic>oprD</italic> to reduce susceptibility to colistin (<xref ref-type="bibr" rid="ref26">Fern&#x00E1;ndez et al., 2010</xref>; <xref ref-type="bibr" rid="ref82">Muller et al., 2011</xref>). <italic>mexXY</italic> deletion in ParRS-dependent pathways increased colistin tolerance by upregulating <italic>arnA</italic> and <italic>pmrA</italic> expression. The simultaneous overexpression of the <italic>arn</italic> opern and <italic>mexXY</italic> induced by the dual activation of PmrAB and ParRS contributed to the high-level resistance of the <italic>pmrB</italic> mutants to colistin, suggesting that the synergistic effect of efflux pumps and LPS modification promoted the development of colistin resistance (<xref ref-type="bibr" rid="ref103">Puja et al., 2020</xref>) (<xref rid="fig3" ref-type="fig">Figure 3</xref>). In another study on the development of cross-resistance to colistin by exposing <italic>P. aeruginosa</italic> to chlorhexidine, proteomics revealed that the upregulation of MexA expression might be related to colistin resistance (<xref ref-type="bibr" rid="ref37">Hashemi et al., 2019</xref>). <xref ref-type="bibr" rid="ref137">Zhang W. et al. (2021)</xref> also observed significant upregulation of <italic>mexAB</italic>-<italic>oprM</italic> in laboratory-induced colistin-resistant <italic>P. aeruginosa</italic>. These results were similar to the previous findings of Pamp et al., who found that MexAB was involved in colistin tolerance, especially in adapting different subpopulations of bacteria to colistin in <italic>P. aeruginosa</italic> biofilms (<xref ref-type="bibr" rid="ref94">Pamp et al., 2008</xref>). The efflux pump activator MerR induced mexAB-oprM and mexEF-oprN to participate in biofilm tolerance and acted as a repressor of <italic>phoPQ</italic> to participate in colistin resistance (<xref ref-type="bibr" rid="ref15">Chambers and Sauer, 2013</xref>). In <italic>P. aeruginosa</italic>, the efflux pump is involved in the transport of signal molecules, and its expression can also be affected by the QS system. The genes related to QS were upregulated when <italic>P. aeruginosa</italic> was exposed to subinhibitory colistin concentration (<xref rid="fig3" ref-type="fig">Figure 3</xref>) (<xref ref-type="bibr" rid="ref20">Cummins et al., 2009</xref>). However, whether this pathway can promote colistin resistance by activating efflux pumps or biofilms remains to be confirmed.</p>
<p><italic>rsmA</italic> is a post-transcriptional regulatory protein involved in regulating various virulence-related genes, and its deletion causes overexpression of the MexEF-OprN pump and downregulation of type III secretion (<xref ref-type="bibr" rid="ref13">Burrowes et al., 2006</xref>). However, the disruption of type III via secretion <italic>rsmA</italic> is associated with the overexpression of MexCD-OprJ or MexEF-OprN (<xref ref-type="bibr" rid="ref65">Linares et al., 2005</xref>; <xref ref-type="bibr" rid="ref78">Mlynarcik and Kolar, 2019</xref>). On exposure to different membrane-targeted drugs, these strains can mobilize various genetic determinants, such as <italic>pmr</italic> operons and efflux pumps, in response to environmental stresses (<xref ref-type="bibr" rid="ref19">Chiang et al., 2012</xref>). The MexAB-oprM, MexCD-oprJ, and MuxABC-opmB efflux pumps all contribute to colistin-tolerant subpopulations (<xref ref-type="bibr" rid="ref19">Chiang et al., 2012</xref>).</p>
</sec>
<sec id="sec9">
<title><italic>Stenotrophomonas maltophilia</italic></title>
<p><italic>Stenotrophomonas maltophilia</italic> is widespread in the natural environment and exhibits natural resistance to numerous antibiotics, significantly limiting clinical use options. Despite colistin&#x2019;s <italic>in vitro</italic> antimicrobial activity, the assessment of colistin susceptibility in <italic>S. maltophilia</italic> is influenced by various factors <italic>in vitro</italic>. (<xref ref-type="bibr" rid="ref76">Mart&#x00ED;nez-Servat et al., 2018</xref>). Lin et al. found that MacABCsm had a broader substrate spectrum on macrolides, aminoglycosides, and polymyxin than its counterpart in <italic>E. coli</italic>, and the deletion of MacAB resulted in a significant decrease in the colistin MIC of <italic>S. maltophilia</italic> isolates (<xref ref-type="bibr" rid="ref63">Lin et al., 2014</xref>). Meanwhile, MacABCsm was stably expressed in <italic>S. maltophilia</italic>, associated with intrinsic resistance (<xref ref-type="bibr" rid="ref63">Lin et al., 2014</xref>). Although multiple genes encoding efflux pumps have been identified in colistin-resistant <italic>S. maltophilia</italic>, their specific contribution to colistin resistance remains elucidated (<xref ref-type="bibr" rid="ref58">Li et al., 2019</xref>).</p>
</sec>
<sec id="sec10">
<title><italic>Aeromonas hydrophila</italic></title>
<p><italic>Aeromonas hydrophila</italic> is a common group of opportunistic pathogens in the <italic>Aeromonas</italic> genus associated with aquatic environments. The AheABC efflux pump regulates the efflux of cefoperazone, cefuroxime, erythromycin, pristinamycin, and trityltin in <italic>A. hydrophila</italic> and participates in its MDR phenotype (<xref ref-type="bibr" rid="ref42">Hernould et al., 2008</xref>). A recent study showed that the expression levels of three putative RND efflux pump genes, AHA0021, AHA1320, and AheB, significantly increased in MDR <italic>A. hydrophila</italic>. Also, PA&#x03B2;N significantly reduced the MIC of piperacillin/tazobactam, imipenem, erythromycin, and polymyxin B, suggesting the contribution of the RND efflux pump to colistin resistance (<xref ref-type="bibr" rid="ref68">Lo et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="sec11">
<title>Efflux pumps are associated with intrinsic colistin resistance in other gram-negative bacteria</title>
<sec id="sec12">
<title><italic>Serratia marcescens</italic> and <italic>Proteus mirabilis</italic></title>
<p><italic>Proteus</italic> and <italic>S. marcescens</italic> are also common but easily overlooked opportunistic pathogens in clinical infections, often showing inherent resistance to colistin. LPS modification mediated by L-Ara4N in lipid A, Kdo residues, and <italic>arnBCADTEF</italic> operon contributes to the intrinsic resistance of <italic>P. mirabilis</italic> and <italic>S. marcescens</italic> to colistin (<xref ref-type="bibr" rid="ref90">Olaitan et al., 2014</xref>). A recent study showed that the ABC transporter MacAB contributed to the intrinsic colistin resistance of <italic>S. marcescens</italic>, which was previously thought to be associated with the efflux of macrolide antibiotics and could be constitutively expressed with <italic>tolC</italic> (<xref ref-type="bibr" rid="ref111">Shirshikova et al., 2021</xref>). In <italic>Salmonella</italic>, <italic>phoP</italic> inhibited <italic>macAB</italic> transcription, and <italic>macAB</italic> deletion attenuated the virulence of <italic>Salmonella</italic> more than the <italic>tolC</italic> mutant (<xref ref-type="bibr" rid="ref86">Nishino et al., 2006</xref>). LPS played a role in colistin resistance and was a critical virulence factor in pathogenesis. However, whether <italic>macAB</italic> in <italic>S. marcescens</italic> is associated with PhoPQ or other TCSs remains to be investigated. The MFS efflux pump family SmvA was overexpressed in <italic>K. pneumoniae</italic> with increased resistance to multiple cationic biocides (chlorhexidine and octenidine) (<xref ref-type="bibr" rid="ref123">Wand et al., 2019</xref>). Another study on <italic>P. mirabilis</italic> demonstrated that SmvA expression was insufficient to explain the differences in polymyxin B MIC of these intrinsically resistant isolates (<xref ref-type="bibr" rid="ref98">Pelling et al., 2019</xref>).</p>
</sec>
<sec id="sec13">
<title><italic>Neisseria</italic> spp.</title>
<p>Among <italic>Neisseria</italic> spp., <italic>N. meningitidis</italic> and <italic>N. gonorrhoeae</italic> are closely associated with clinical infections and causative agents of bacterial meningitis and gonorrhea, respectively. The MtrCDE efflux system in <italic>Neisseria</italic> is thought to be the leading cause of the low-level intrinsic resistance to colistin (<xref ref-type="bibr" rid="ref79">Moffatt et al., 2019</xref>). MtrCDE is Neisseria&#x2019;s most widely explored RND pump, contributing to resistance to &#x03B2;-lactams, macrolides, rifampicin, detergents, bile salts, and cationic polypeptides. The contribution of MtrCDE to colistin resistance has been demonstrated <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref121">Tzeng et al., 2005</xref>). The epistatic effects between <italic>mtrD</italic> and <italic>mtr</italic> promoter region promote the formation of the multidrug resistance phenotype (<xref ref-type="bibr" rid="ref122">Wadsworth et al., 2018</xref>).</p>
</sec>
<sec id="sec14">
<title><italic>Yersinia</italic> spp.</title>
<p><italic>Yersinia</italic> comprises dozens of species, and only <italic>Y. pestis</italic>, <italic>Y. pseudotuberculosis</italic>, and <italic>Y</italic>. <italic>enterocolitica</italic> are closely related to clinical infection. Significantly different from other bacteria, the resistance of <italic>Yersinia</italic> to cationic peptides (including colistin) is affected by temperature as well as individual differences, which may be related to the successful adaptation of these pathogens at different sites (<xref ref-type="bibr" rid="ref6">Bengoechea et al., 1996</xref>, <xref ref-type="bibr" rid="ref7">1998</xref>). Bengoechea et al. found that the <italic>rosAB</italic> locus encoded a temperature-regulated efflux pump and could participate in colistin efflux in response to antibiotic pressure (<xref ref-type="bibr" rid="ref8">Bengoechea and Skurnik, 2000</xref>).</p>
</sec>
<sec id="sec15">
<title><italic>Burkholderia</italic></title>
<p>Like <italic>S. maltophilia</italic>, <italic>Burkholderia</italic> is widespread in the environment and exhibits inherent resistance to various antibiotics, including colistin. The primary mechanism of intrinsic resistance of <italic>Burkholderia</italic> to colistin is still Ara4N synthesis and Ara4N transfer to lipid A (<xref ref-type="bibr" rid="ref70">Loutet and Valvano, 2011</xref>). A previously suggested <italic>norM</italic> belonging to MATE transporters contributes to colistin resistance, but it is mainly associated with the presence of tetracycline (<xref ref-type="bibr" rid="ref25">Fehlner-Gardiner and Valvano, 2002</xref>). Another class of <italic>yej</italic> operons (<italic>yejA1</italic>, <italic>yejA2</italic>, <italic>yejB</italic>, <italic>yejE</italic>, and <italic>yejF</italic>) belonging to ABC transporters was also found to be directly activated by colistin and conferred colistin resistance. To further clarify the contribution of the efflux pump to colistin resistance, <xref ref-type="bibr" rid="ref140">Zoaiter et al. (2023)</xref> found that CCCP restored susceptibility in <italic>Burkholderia</italic> isolates, while VRP, PA&#x03B2;N, and RSP did not. The genomic analysis showed that the efflux pump genes YejABEF, LolCDE, and NorM were widely present in these isolates (<xref ref-type="bibr" rid="ref140">Zoaiter et al., 2023</xref>). This result suggested that multiple efflux pumps might be involved in the intrinsic colistin resistance of <italic>Burkholderia</italic>. Another study explored the interaction of the Amrab-OprA, BpeEF-OprC, and BpeAB-OprB efflux pumps with the outer membrane permeability and showed that only the simultaneous presence of Amrab-OprA inactivation and hyperporination contributed to the increased susceptibility to colistin (<xref ref-type="bibr" rid="ref52">Krishnamoorthy et al., 2019</xref>).</p>
</sec>
</sec>
<sec id="sec16">
<title>Future perspectives</title>
<p>Compared with the two-component regulatory system PmrAB/PhoPQ and <italic>mcr</italic>-mediated colistin resistance, relatively little information is available on the role played by efflux pumps in this regard. Although these findings suggest the possibility of EPIs reversing polymyxin resistance, EPI application to reverse colistin resistance still needs to be confirmed. CCCP has advantages over other EPIs in reversing colistin resistance, and its cytotoxicity limits its clinical application. Therefore, identifying these atypical resistant strains and developing suitable EPIs are crucial. Whether EPIs can reverse polymyxin resistance mediated by polymyxin-degrading protease and RpoE stress response pathways not involving structural changes in lipid A is uncertain. On the contrary, various reports showed that the bactericidal effect of CCCP on colistin was different. Therefore, the impact of CCCP on the bacterial intracellular microenvironment remains to be clarified. Other efflux pumps that rely on proton power to mediate colistin resistance remain to be identified. Since efflux pumps and associated transcription factors play a role in response to environmental stress, their activation can provide an adaptive advantage for these antibiotics-resistant strains in specific environments (<xref ref-type="bibr" rid="ref43">Holden and Webber, 2020</xref>). However, the fitness effects of efflux pumps and related transcription factors mediating colistin resistance are still less explored compared with those of colistin resistance caused by LPS-related locus variants. The role of efflux pumps and their regulators in LPS synthesis, transport, and outer membrane integrity in colistin-resistant strains with different genetic and living backgrounds remains to be determined.</p>
</sec>
<sec sec-type="conclusions" id="sec17">
<title>Conclusion</title>
<p>The efflux pumps&#x2019; structure, function, and regulation have been previously summarized in detail in many comprehensive reviews (<xref ref-type="bibr" rid="ref100">Piddock, 2006</xref>; <xref ref-type="bibr" rid="ref104">Puzari and Chetia, 2017</xref>; <xref ref-type="bibr" rid="ref87">Nishino et al., 2021</xref>). We specifically examined the effects of efflux pumps, their regulators, and EPIs on colistin susceptibility. Efflux pumps play a role in the classical pathway of antibiotic resistance and participate in the efflux of various metabolites and signaling molecules. The correlation between efflux pumps and their transcriptional regulators and LPS modification/transport indicates colistin resistance mechanisms&#x2019; complexity. The observation that efflux pumps and their regulator (<italic>ramR</italic>, KpnEF, KexD, etc.) independently mediate colistin susceptibility in some isolates indicates colistin resistance mechanisms&#x2019; diversity. The effect of efflux pumps on colistin susceptibility is also mediated through multiple pathways, such as heteroresistance and tolerance. These findings indicate that the multidrug resistance efflux pumps may participate in different stages of occurrence and development of colistin resistance. Overall, the contribution of efflux pumps and their regulators to colistin resistance is multi-pathway, including outer membrane permeability, LPS modification, and environmental adaptation, besides the direct involvement in efflux. For developing adjuvants acting as EPIs, it is critical to identify colistin-resistant strains that are <italic>mcr</italic>-negative and lack specific mutations related to LPS modification.</p>
</sec>
<sec id="sec18">
<title>Author contributions</title>
<p>YD, JH, WX, and ZZ contributed to the conception and design of the study. WX, XX, and CJ collected and explored literature. JH, MT, and GL performed the diagrams visualization. YD, ZZ, CY, JH, and JL prepared and revised the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="sec19">
<title>Funding</title>
<p>This work was supported by the Sichuan Science and Technology Program (2020YFQ0045 and 2021YFS0329) and School-level scientific research project of Southwest Medical University (2019ZQN017).</p>
</sec>
<sec sec-type="COI-statement" id="sec20">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec sec-type="supplementary-material" id="sec21">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2023.1207441/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2023.1207441/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.tif" id="SM1" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alteri</surname> <given-names>C. J.</given-names></name> <name><surname>Lindner</surname> <given-names>J. R.</given-names></name> <name><surname>Reiss</surname> <given-names>D. J.</given-names></name> <name><surname>Smith</surname> <given-names>S. N.</given-names></name> <name><surname>Mobley</surname> <given-names>H. L.</given-names></name></person-group> (<year>2011</year>). <article-title>The broadly conserved regulator PhoP links pathogen virulence and membrane potential in <italic>Escherichia coli</italic></article-title>. <source>Mol. Microbiol.</source> <volume>82</volume>, <fpage>145</fpage>&#x2013;<lpage>163</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07804.x</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>D. I.</given-names></name> <name><surname>Hughes</surname> <given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbiological effects of sublethal levels of antibiotics</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>12</volume>, <fpage>465</fpage>&#x2013;<lpage>478</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro3270</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayoub Moubareck</surname> <given-names>C.</given-names></name> <name><surname>Hammoudi Halat</surname> <given-names>D.</given-names></name></person-group> (<year>2020</year>). <article-title>Insights into <italic>Acinetobacter baumannii</italic>: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen</article-title>. <source>Antibiotics (Basel)</source> <volume>9</volume>:<fpage>119</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antibiotics9030119</pub-id>, PMID: <pub-id pub-id-type="pmid">32178356</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname> <given-names>S. A.</given-names></name> <name><surname>Rolain</surname> <given-names>J. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and gram-negative bacteria</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>1862</fpage>&#x2013;<lpage>1871</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dky134</pub-id>, PMID: <pub-id pub-id-type="pmid">29718423</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bazyleu</surname> <given-names>A.</given-names></name> <name><surname>Kumar</surname> <given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in <italic>Acinetobacter baumannii</italic> ATCC19606T</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>357</volume>, <fpage>136</fpage>&#x2013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1574-6968.12530</pub-id>, PMID: <pub-id pub-id-type="pmid">25039371</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>D&#x00ED;az</surname> <given-names>R.</given-names></name> <name><surname>Moriy&#x00F3;n</surname> <given-names>I.</given-names></name></person-group> (<year>1996</year>). <article-title>Outer membrane differences between pathogenic and environmental <italic>Yersinia enterocolitica</italic> biogroups probed with hydrophobic permeants and polycationic peptides</article-title>. <source>Infect. Immun.</source> <volume>64</volume>, <fpage>4891</fpage>&#x2013;<lpage>4899</lpage>. doi: <pub-id pub-id-type="doi">10.1128/iai.64.12.4891-4899.1996</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>Lindner</surname> <given-names>B.</given-names></name> <name><surname>Seydel</surname> <given-names>U.</given-names></name> <name><surname>Ram&#x00F3;n</surname> <given-names>D.</given-names></name> <name><surname>Ignacio</surname> <given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Yersinia pseudotuberculosis and <italic>Yersinia pestis</italic> are more resistant to bactericidal cationic peptides than <italic>Yersinia enterocolitica</italic></article-title>. <source>Microbiology (Read.)</source> <volume>144</volume>, <fpage>1509</fpage>&#x2013;<lpage>1515</lpage>. doi: <pub-id pub-id-type="doi">10.1099/00221287-144-6-1509</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>Skurnik</surname> <given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in yersinia</article-title>. <source>Mol. Microbiol.</source> <volume>37</volume>, <fpage>67</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.01956.x</pub-id>, PMID: <pub-id pub-id-type="pmid">10931306</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bialvaei</surname> <given-names>A. Z.</given-names></name> <name><surname>Samadi Kafil</surname> <given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Colistin, mechanisms and prevalence of resistance</article-title>. <source>Curr. Med. Res. Opin.</source> <volume>31</volume>, <fpage>707</fpage>&#x2013;<lpage>721</lpage>. doi: <pub-id pub-id-type="doi">10.1185/03007995.2015.1018989</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boinett</surname> <given-names>C. J.</given-names></name> <name><surname>Cain</surname> <given-names>A. K.</given-names></name> <name><surname>Hawkey</surname> <given-names>J.</given-names></name> <name><surname>Do Hoang</surname> <given-names>N. T.</given-names></name> <name><surname>Khanh</surname> <given-names>N. N. T.</given-names></name> <name><surname>Thanh</surname> <given-names>D. P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Clinical and laboratory-induced colistin-resistance mechanisms in <italic>Acinetobacter baumannii</italic></article-title>. <source>Microb. Genom.</source> <volume>5</volume>:<fpage>e000246</fpage>. doi: <pub-id pub-id-type="doi">10.1099/mgen.0.000246</pub-id>, PMID: <pub-id pub-id-type="pmid">30720421</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolourchi</surname> <given-names>N.</given-names></name> <name><surname>Shahcheraghi</surname> <given-names>F.</given-names></name> <name><surname>Giske</surname> <given-names>C. G.</given-names></name> <name><surname>Nematzadeh</surname> <given-names>S.</given-names></name> <name><surname>Noori Goodarzi</surname> <given-names>N.</given-names></name> <name><surname>Solgi</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2021a</year>). <article-title>Comparative genome analysis of colistin-resistant OXA-48-producing <italic>Klebsiella pneumoniae</italic> clinical strains isolated from two Iranian hospitals</article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source> <volume>20</volume>:<fpage>74</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12941-021-00479-y</pub-id>, PMID: <pub-id pub-id-type="pmid">34688302</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolourchi</surname> <given-names>N.</given-names></name> <name><surname>Shahcheraghi</surname> <given-names>F.</given-names></name> <name><surname>Giske</surname> <given-names>C. G.</given-names></name> <name><surname>Nematzadeh</surname> <given-names>S.</given-names></name> <name><surname>Solgi</surname> <given-names>H.</given-names></name> <name><surname>Badmasti</surname> <given-names>F.</given-names></name></person-group> (<year>2021b</year>). <article-title>Genome analysis of an OXA-48-producing carbapenem- and colistin-resistant <italic>Klebsiella pneumoniae</italic> sequence type 11 clone isolated from an inpatient</article-title>. <source>Gene Rep.</source> <volume>25</volume>:<fpage>101394</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.genrep.2021.101394</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burrowes</surname> <given-names>E.</given-names></name> <name><surname>Baysse</surname> <given-names>C.</given-names></name> <name><surname>Adams</surname> <given-names>C.</given-names></name> <name><surname>O'Gara</surname> <given-names>F.</given-names></name></person-group> (<year>2006</year>). <article-title>Influence of the regulatory protein RsmA on cellular functions in <italic>Pseudomonas aeruginosa</italic> PAO1, as revealed by transcriptome analysis</article-title>. <source>Microbiology (Read.)</source> <volume>152</volume>, <fpage>405</fpage>&#x2013;<lpage>418</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.28324-0</pub-id>, PMID: <pub-id pub-id-type="pmid">16436429</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname> <given-names>H. J.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>R. T.</given-names></name> <name><surname>Pos</surname> <given-names>K. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>58</volume>, <fpage>4767</fpage>&#x2013;<lpage>4772</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.02733-13</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>J. R.</given-names></name> <name><surname>Sauer</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>The MerR-like regulator BrlR impairs <italic>Pseudomonas aeruginosa</italic> biofilm tolerance to colistin by repressing PhoPQ</article-title>. <source>J. Bacteriol.</source> <volume>195</volume>, <fpage>4678</fpage>&#x2013;<lpage>4688</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00834-13</pub-id>, PMID: <pub-id pub-id-type="pmid">23935054</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheah</surname> <given-names>S. E.</given-names></name> <name><surname>Johnson</surname> <given-names>M. D.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Tsuji</surname> <given-names>B. T.</given-names></name> <name><surname>Forrest</surname> <given-names>A.</given-names></name> <name><surname>Bulitta</surname> <given-names>J. B.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Polymyxin resistance in <italic>Acinetobacter baumannii</italic>: genetic mutations and transcriptomic changes in response to clinically relevant dosage regimens</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>26233</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep26233</pub-id>, PMID: <pub-id pub-id-type="pmid">27195897</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name> <name><surname>Lu</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Deciphering colistin heteroresistance in <italic>Acinetobacter baumannii</italic> clinical isolates from Wenzhou, China</article-title>. <source>J. Antibiot. (Tokyo)</source> <volume>73</volume>, <fpage>463</fpage>&#x2013;<lpage>470</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41429-020-0289-2</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>Y. H.</given-names></name> <name><surname>Lin</surname> <given-names>T. L.</given-names></name> <name><surname>Lin</surname> <given-names>Y. T.</given-names></name> <name><surname>Wang</surname> <given-names>J. T.</given-names></name></person-group> (<year>2018</year>). <article-title>A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in <italic>Klebsiella pneumoniae</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>1509</fpage>&#x2013;<lpage>1516</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dky054</pub-id>, PMID: <pub-id pub-id-type="pmid">29506266</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname> <given-names>W. C.</given-names></name> <name><surname>Pamp</surname> <given-names>S. J.</given-names></name> <name><surname>Nilsson</surname> <given-names>M.</given-names></name> <name><surname>Givskov</surname> <given-names>M.</given-names></name> <name><surname>Tolker-Nielsen</surname> <given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>The metabolically active subpopulation in <italic>Pseudomonas aeruginosa</italic> biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>65</volume>, <fpage>245</fpage>&#x2013;<lpage>256</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-695X.2012.00929.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22251216</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummins</surname> <given-names>J.</given-names></name> <name><surname>Reen</surname> <given-names>F. J.</given-names></name> <name><surname>Baysse</surname> <given-names>C.</given-names></name> <name><surname>Mooij</surname> <given-names>M. J.</given-names></name> <name><surname>O'Gara</surname> <given-names>F.</given-names></name></person-group> (<year>2009</year>). <article-title>Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Microbiology (Read.)</source> <volume>155</volume>, <fpage>2826</fpage>&#x2013;<lpage>2837</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.025643-0</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Majumdar</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>J.</given-names></name> <name><surname>Fookes</surname> <given-names>M.</given-names></name> <name><surname>McAteer</surname> <given-names>S. P.</given-names></name> <name><surname>Llobet</surname> <given-names>E.</given-names></name> <name><surname>Finn</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Elucidation of the RamA regulon in <italic>Klebsiella pneumoniae</italic> reveals a role in LPS regulation</article-title>. <source>PLoS Pathog.</source> <volume>11</volume>:<fpage>e1004627</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1004627</pub-id>, PMID: <pub-id pub-id-type="pmid">25633080</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>N.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Lu</surname> <given-names>J.</given-names></name> <name><surname>Cai</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical gram-negative bacteria: a molecular epidemiological study</article-title>. <source>Lancet Microbe</source> <volume>3</volume>, <fpage>e846</fpage>&#x2013;<lpage>e856</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s2666-5247(22)00221-x</pub-id>, PMID: <pub-id pub-id-type="pmid">36202114</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname> <given-names>M. E.</given-names></name> <name><surname>Kasiakou</surname> <given-names>S. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections</article-title>. <source>Clin. Infect. Dis.</source> <volume>40</volume>, <fpage>1333</fpage>&#x2013;<lpage>1341</lpage>. doi: <pub-id pub-id-type="doi">10.1086/429323</pub-id>, PMID: <pub-id pub-id-type="pmid">15825037</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname> <given-names>M. E.</given-names></name> <name><surname>Makris</surname> <given-names>G. C.</given-names></name> <name><surname>Dimopoulos</surname> <given-names>G.</given-names></name> <name><surname>Matthaiou</surname> <given-names>D. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Heteroresistance: a concern of increasing clinical significance?</article-title> <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>101</fpage>&#x2013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01912.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18093235</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fehlner-Gardiner</surname> <given-names>C. C.</given-names></name> <name><surname>Valvano</surname> <given-names>M. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Cloning and characterization of the <italic>Burkholderia vietnamiensis</italic> norM gene encoding a multi-drug efflux protein</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>215</volume>, <fpage>279</fpage>&#x2013;<lpage>283</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-6968.2002.tb11403.x</pub-id>, PMID: <pub-id pub-id-type="pmid">12399047</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x00E1;ndez</surname> <given-names>L.</given-names></name> <name><surname>Gooderham</surname> <given-names>W. J.</given-names></name> <name><surname>Bains</surname> <given-names>M.</given-names></name> <name><surname>McPhee</surname> <given-names>J. B.</given-names></name> <name><surname>Wiegand</surname> <given-names>I.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in <italic>Pseudomonas aeruginosa</italic> is mediated by the novel two-component regulatory system ParR-ParS</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>3372</fpage>&#x2013;<lpage>3382</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00242-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20547815</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x00E1;ndez</surname> <given-names>L.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>25</volume>, <fpage>661</fpage>&#x2013;<lpage>681</lpage>. doi: <pub-id pub-id-type="doi">10.1128/cmr.00043-12</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>L.</given-names></name> <name><surname>Lyu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Trends in drug resistance of <italic>Acinetobacter baumannii</italic> over a 10-year period: Nationwide data from the China surveillance of antimicrobial resistance program</article-title>. <source>Chin. Med. J.</source> <volume>130</volume>, <fpage>659</fpage>&#x2013;<lpage>664</lpage>. doi: <pub-id pub-id-type="doi">10.4103/0366-6999.201601</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geisinger</surname> <given-names>E.</given-names></name> <name><surname>Isberg</surname> <given-names>R. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria</article-title>. <source>J. Infect. Dis.</source> <volume>215</volume>, <fpage>S9</fpage>&#x2013;<lpage>s17</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiw402</pub-id>, PMID: <pub-id pub-id-type="pmid">28375515</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname> <given-names>S. P. M.</given-names></name> <name><surname>Tajuelo</surname> <given-names>A.</given-names></name> <name><surname>L&#x00F3;pez-Siles</surname> <given-names>M.</given-names></name> <name><surname>McConnell</surname> <given-names>M. J.</given-names></name></person-group> (<year>2021</year>). <article-title>Subinhibitory concentrations of clinically-relevant antimicrobials affect resistance-nodulation-division family promoter activity in <italic>Acinetobacter baumannii</italic></article-title>. <source>Front. Microbiol.</source> <volume>12</volume>:<fpage>780201</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.780201</pub-id>, PMID: <pub-id pub-id-type="pmid">34925284</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gogry</surname> <given-names>F. A.</given-names></name> <name><surname>Siddiqui</surname> <given-names>M. T.</given-names></name> <name><surname>Sultan</surname> <given-names>I.</given-names></name> <name><surname>Haq</surname> <given-names>Q. M. R.</given-names></name></person-group> (<year>2021</year>). <article-title>Current update on intrinsic and acquired colistin resistance mechanisms in bacteria</article-title>. <source>Front. Med. (Lausanne)</source> <volume>8</volume>:<fpage>677720</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2021.677720</pub-id>, PMID: <pub-id pub-id-type="pmid">34476235</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goli</surname> <given-names>H. R.</given-names></name> <name><surname>Nahaei</surname> <given-names>M. R.</given-names></name> <name><surname>Ahangarzadeh Rezaee</surname> <given-names>M.</given-names></name> <name><surname>Hasani</surname> <given-names>A.</given-names></name> <name><surname>Samadi Kafil</surname> <given-names>H.</given-names></name> <name><surname>Aghazadeh</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Emergence of colistin resistant <italic>Pseudomonas aeruginosa</italic> at Tabriz hospitals, Iran</article-title>. <source>IJM</source> <volume>8</volume>, <fpage>62</fpage>&#x2013;<lpage>69</lpage>. Available at: <ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/27092226/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/27092226/</ext-link> PMID: <pub-id pub-id-type="pmid">27092226</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gr&#x00E9;zal</surname> <given-names>G.</given-names></name> <name><surname>Spohn</surname> <given-names>R.</given-names></name> <name><surname>M&#x00E9;hi</surname> <given-names>O.</given-names></name> <name><surname>Dunai</surname> <given-names>A.</given-names></name> <name><surname>L&#x00E1;z&#x00E1;r</surname> <given-names>V.</given-names></name> <name><surname>B&#x00E1;lint</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Plasticity and stereotypic rewiring of the transcriptome upon bacterial evolution of antibiotic resistance</article-title>. <source>Mol. Biol. Evol.</source> <volume>40</volume>:<fpage>msad020</fpage>. doi: <pub-id pub-id-type="doi">10.1093/molbev/msad020</pub-id>, PMID: <pub-id pub-id-type="pmid">36718533</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grkovic</surname> <given-names>S.</given-names></name> <name><surname>Brown</surname> <given-names>M. H.</given-names></name> <name><surname>Skurray</surname> <given-names>R. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Regulation of bacterial drug export systems</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>66</volume>, <fpage>671</fpage>&#x2013;<lpage>701</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mmbr.66.4.671-701.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12456787</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>M.</given-names></name> <name><surname>Ye</surname> <given-names>F.</given-names></name> <name><surname>Jovanovic</surname> <given-names>M.</given-names></name> <name><surname>Kotta-Loizou</surname> <given-names>I.</given-names></name> <name><surname>Xu</surname> <given-names>Q.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Structures of class I and class II transcription complexes reveal the molecular basis of RamA-dependent transcription activation</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>9</volume>:<fpage>e2103669</fpage>. doi: <pub-id pub-id-type="doi">10.1002/advs.202103669</pub-id>, PMID: <pub-id pub-id-type="pmid">34761556</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname> <given-names>M. M.</given-names></name> <name><surname>Holden</surname> <given-names>B. S.</given-names></name> <name><surname>Coburn</surname> <given-names>J.</given-names></name> <name><surname>Taylor</surname> <given-names>M. F.</given-names></name> <name><surname>Weber</surname> <given-names>S.</given-names></name> <name><surname>Hilton</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Proteomic analysis of resistance of gram-negative bacteria to chlorhexidine and impacts on susceptibility to colistin, antimicrobial peptides, and Ceragenins</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>:<fpage>210</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2019.00210</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>X.</given-names></name> <name><surname>Lu</surname> <given-names>F.</given-names></name> <name><surname>Yuan</surname> <given-names>F.</given-names></name> <name><surname>Jiang</surname> <given-names>D.</given-names></name> <name><surname>Zhao</surname> <given-names>P.</given-names></name> <name><surname>Zhu</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Biofilm formation caused by clinical <italic>Acinetobacter baumannii</italic> isolates is associated with overexpression of the AdeFGH efflux pump</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>4817</fpage>&#x2013;<lpage>4825</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00877-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26033730</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>G. X.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Crow</surname> <given-names>R. R.</given-names></name> <name><surname>Thorpe</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Kumar</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in <italic>Enterobacter cloacae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3954</fpage>&#x2013;<lpage>3957</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00094-11</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname> <given-names>R.</given-names></name> <name><surname>Crane</surname> <given-names>B.</given-names></name> <name><surname>Powell</surname> <given-names>D.</given-names></name> <name><surname>Deveson Lucas</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Aranda</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>The transcriptomic response of <italic>Acinetobacter baumannii</italic> to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>70</volume>, <fpage>1303</fpage>&#x2013;<lpage>1313</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dku536</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname> <given-names>R.</given-names></name> <name><surname>Vithanage</surname> <given-names>N.</given-names></name> <name><surname>Harrison</surname> <given-names>P.</given-names></name> <name><surname>Seemann</surname> <given-names>T.</given-names></name> <name><surname>Coutts</surname> <given-names>S.</given-names></name> <name><surname>Moffatt</surname> <given-names>J. H.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Colistin-resistant, lipopolysaccharide-deficient <italic>Acinetobacter baumannii</italic> responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-&#x03B2;-1,6-N-acetylglucosamine</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>59</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.05191-11</pub-id>, PMID: <pub-id pub-id-type="pmid">22024825</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hernould</surname> <given-names>M.</given-names></name> <name><surname>Gagn&#x00E9;</surname> <given-names>S.</given-names></name> <name><surname>Fournier</surname> <given-names>M.</given-names></name> <name><surname>Quentin</surname> <given-names>C.</given-names></name> <name><surname>Arpin</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of the AheABC efflux pump in <italic>Aeromonas hydrophila</italic> intrinsic multidrug resistance</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>1559</fpage>&#x2013;<lpage>1563</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.01052-07</pub-id>, PMID: <pub-id pub-id-type="pmid">18268083</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>E. R.</given-names></name> <name><surname>Webber</surname> <given-names>M. A.</given-names></name></person-group> (<year>2020</year>). <article-title>MarA, RamA, and SoxS as mediators of the stress response: survival at a cost</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>828</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.00828</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Fang</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>Q.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Colistin resistance in <italic>Acinetobacter baumannii</italic> MDR-ZJ06 revealed by a multiomics approach</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00045</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L.</given-names></name> <name><surname>Feng</surname> <given-names>Y.</given-names></name> <name><surname>Zong</surname> <given-names>Z.</given-names></name></person-group> (<year>2019</year>). <article-title>Heterogeneous resistance to colistin in <italic>Enterobacter cloacae</italic> complex due to a new small transmembrane protein</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>74</volume>, <fpage>2551</fpage>&#x2013;<lpage>2558</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkz236</pub-id>, PMID: <pub-id pub-id-type="pmid">31169899</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeannot</surname> <given-names>K.</given-names></name> <name><surname>Bolard</surname> <given-names>A.</given-names></name> <name><surname>Pl&#x00E9;siat</surname> <given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Resistance to polymyxins in gram-negative organisms</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>49</volume>, <fpage>526</fpage>&#x2013;<lpage>535</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2016.11.029</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeannot</surname> <given-names>K.</given-names></name> <name><surname>Sobel</surname> <given-names>M. L.</given-names></name> <name><surname>El Garch</surname> <given-names>F.</given-names></name> <name><surname>Poole</surname> <given-names>K.</given-names></name> <name><surname>Pl&#x00E9;siat</surname> <given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Induction of the MexXY efflux pump in <italic>Pseudomonas aeruginosa</italic> is dependent on drug-ribosome interaction</article-title>. <source>J. Bacteriol.</source> <volume>187</volume>, <fpage>5341</fpage>&#x2013;<lpage>5346</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.187.15.5341-5346.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">16030228</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapach</surname> <given-names>G.</given-names></name> <name><surname>Nuri</surname> <given-names>R.</given-names></name> <name><surname>Schmidt</surname> <given-names>C.</given-names></name> <name><surname>Danin</surname> <given-names>A.</given-names></name> <name><surname>Ferrera</surname> <given-names>S.</given-names></name> <name><surname>Savidor</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Loss of the periplasmic chaperone Skp and mutations in the efflux pump AcrAB-TolC play a role in acquired resistance to antimicrobial peptides in <italic>Salmonella typhimurium</italic></article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>189</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.00189</pub-id>, PMID: <pub-id pub-id-type="pmid">32210923</pub-id></citation></ref>
<ref id="ref001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelesidis</surname> <given-names>T.</given-names></name> <name><surname>Falagas</surname> <given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The safety of polymyxin antibiotics</article-title>. <source>Expert Opin. Drug Saf.</source> <volume>14</volume>, <fpage>1687</fpage>&#x2013;<lpage>1701</lpage>. doi: <pub-id pub-id-type="doi">10.1517/14740338.2015.1088520</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. J.</given-names></name> <name><surname>Cho</surname> <given-names>H.</given-names></name> <name><surname>Ko</surname> <given-names>K. S.</given-names></name></person-group> (<year>2022</year>). <article-title>Comparative analysis of the colistin resistance-regulating gene cluster in klebsiella species</article-title>. <source>J. Microbiol.</source> <volume>60</volume>, <fpage>461</fpage>&#x2013;<lpage>468</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12275-022-1640-z</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. A.</given-names></name> <name><surname>Ryu</surname> <given-names>S. Y.</given-names></name> <name><surname>Seo</surname> <given-names>I.</given-names></name> <name><surname>Suh</surname> <given-names>S. I.</given-names></name> <name><surname>Suh</surname> <given-names>M. H.</given-names></name> <name><surname>Baek</surname> <given-names>W. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Biofilm formation and colistin susceptibility of <italic>Acinetobacter baumannii</italic> isolated from Korean nosocomial samples</article-title>. <source>Microb. Drug Resist.</source> <volume>21</volume>, <fpage>452</fpage>&#x2013;<lpage>457</lpage>. doi: <pub-id pub-id-type="doi">10.1089/mdr.2014.0236</pub-id>, PMID: <pub-id pub-id-type="pmid">25714496</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koutsolioutsou</surname> <given-names>A.</given-names></name> <name><surname>Pe&#x00F1;a-Llopis</surname> <given-names>S.</given-names></name> <name><surname>Demple</surname> <given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical <italic>Escherichia coli</italic> isolates</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>2746</fpage>&#x2013;<lpage>2752</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.49.7.2746-2752.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15980345</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamoorthy</surname> <given-names>G.</given-names></name> <name><surname>Weeks</surname> <given-names>J. W.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Chandler</surname> <given-names>C. E.</given-names></name> <name><surname>Xue</surname> <given-names>H.</given-names></name> <name><surname>Schweizer</surname> <given-names>H. P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Efflux pumps of <italic>Burkholderia thailandensis</italic> control the permeability barrier of the outer membrane</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>:<fpage>e00956-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00956-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31383661</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00E1;z&#x00E1;r</surname> <given-names>V.</given-names></name> <name><surname>Martins</surname> <given-names>A.</given-names></name> <name><surname>Spohn</surname> <given-names>R.</given-names></name> <name><surname>Daruka</surname> <given-names>L.</given-names></name> <name><surname>Gr&#x00E9;zal</surname> <given-names>G.</given-names></name> <name><surname>Fekete</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides</article-title>. <source>Nat. Microbiol.</source> <volume>3</volume>, <fpage>718</fpage>&#x2013;<lpage>731</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-018-0164-0</pub-id>, PMID: <pub-id pub-id-type="pmid">29795541</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>D. H.</given-names></name> <name><surname>Cha</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>D. W.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Kim</surname> <given-names>Y. S.</given-names></name> <name><surname>Oh</surname> <given-names>H. Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Colistin-degrading proteases confer collective resistance to microbial communities during polymicrobial infections</article-title>. <source>Microbiome</source> <volume>10</volume>:<fpage>129</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40168-022-01315-x</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J. H.</given-names></name> <name><surname>Lee</surname> <given-names>K. L.</given-names></name> <name><surname>Yeo</surname> <given-names>W. S.</given-names></name> <name><surname>Park</surname> <given-names>S. J.</given-names></name> <name><surname>Roe</surname> <given-names>J. H.</given-names></name></person-group> (<year>2009</year>). <article-title>SoxRS-mediated lipopolysaccharide modification enhances resistance against multiple drugs in <italic>Escherichia coli</italic></article-title>. <source>J. Bacteriol.</source> <volume>191</volume>, <fpage>4441</fpage>&#x2013;<lpage>4450</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.01474-08</pub-id>, PMID: <pub-id pub-id-type="pmid">19376854</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y. T.</given-names></name> <name><surname>Sun</surname> <given-names>J. R.</given-names></name> <name><surname>Wang</surname> <given-names>Y. C.</given-names></name> <name><surname>Chiu</surname> <given-names>C. H.</given-names></name> <name><surname>Kuo</surname> <given-names>S. C.</given-names></name> <name><surname>Chen</surname> <given-names>T. L.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>55</volume>:<fpage>105956</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105956</pub-id>, PMID: <pub-id pub-id-type="pmid">32278810</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leus</surname> <given-names>I. V.</given-names></name> <name><surname>Weeks</surname> <given-names>J. W.</given-names></name> <name><surname>Bonifay</surname> <given-names>V.</given-names></name> <name><surname>Smith</surname> <given-names>L.</given-names></name> <name><surname>Richardson</surname> <given-names>S.</given-names></name> <name><surname>Zgurskaya</surname> <given-names>H. I.</given-names></name></person-group> (<year>2018</year>). <article-title>Substrate specificities and efflux efficiencies of RND efflux pumps of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Bacteriol.</source> <volume>200</volume>:<fpage>e00049-18</fpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00049-18</pub-id>, PMID: <pub-id pub-id-type="pmid">29661860</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Fu</surname> <given-names>J.</given-names></name> <name><surname>Yin</surname> <given-names>J.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Zhong</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Co-occurrence of colistin and meropenem resistance determinants in a Stenotrophomonas strain isolated from sewage water</article-title>. <source>Microb. Drug Resist.</source> <volume>25</volume>, <fpage>317</fpage>&#x2013;<lpage>325</lpage>. doi: <pub-id pub-id-type="doi">10.1089/mdr.2018.0418</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Lei</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>F.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Genetic diversity of polymyxin-resistance mechanisms in clinical isolates of carbapenem-resistant <italic>Klebsiella pneumoniae</italic>: a multicenter study in China</article-title>. <source>Microbiol. Spectr.</source> <volume>11</volume>:<fpage>e0523122</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.05231-22</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X. Z.</given-names></name> <name><surname>Nikaido</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Efflux-mediated drug resistance in bacteria: an update</article-title>. <source>Drugs</source> <volume>69</volume>, <fpage>1555</fpage>&#x2013;<lpage>1623</lpage>. doi: <pub-id pub-id-type="doi">10.2165/11317030-000000000-00000</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X. Z.</given-names></name> <name><surname>Pl&#x00E9;siat</surname> <given-names>P.</given-names></name> <name><surname>Nikaido</surname> <given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>28</volume>, <fpage>337</fpage>&#x2013;<lpage>418</lpage>. doi: <pub-id pub-id-type="doi">10.1128/cmr.00117-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25788514</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>W.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name> <name><surname>Jia</surname> <given-names>H.</given-names></name> <name><surname>Zhou</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Lin</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Resistance and Heteroresistance to colistin in <italic>Escherichia coli</italic> isolates from Wenzhou, China</article-title>. <source>Infect. Drug Resist.</source> <volume>13</volume>, <fpage>3551</fpage>&#x2013;<lpage>3561</lpage>. doi: <pub-id pub-id-type="doi">10.2147/idr.S273784</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y. T.</given-names></name> <name><surname>Huang</surname> <given-names>Y. W.</given-names></name> <name><surname>Liou</surname> <given-names>R. S.</given-names></name> <name><surname>Chang</surname> <given-names>Y. C.</given-names></name> <name><surname>Yang</surname> <given-names>T. C.</given-names></name></person-group> (<year>2014</year>). <article-title>MacABCsm, an ABC-type tripartite efflux pump of <italic>Stenotrophomonas maltophilia</italic> involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>69</volume>, <fpage>3221</fpage>&#x2013;<lpage>3226</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dku317</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>M. F.</given-names></name> <name><surname>Lin</surname> <given-names>Y. Y.</given-names></name> <name><surname>Lan</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Contribution of EmrAB efflux pumps to colistin resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Microbiol.</source> <volume>55</volume>, <fpage>130</fpage>&#x2013;<lpage>136</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12275-017-6408-5</pub-id>, PMID: <pub-id pub-id-type="pmid">28120193</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linares</surname> <given-names>J. F.</given-names></name> <name><surname>L&#x00F3;pez</surname> <given-names>J. A.</given-names></name> <name><surname>Camafeita</surname> <given-names>E.</given-names></name> <name><surname>Albar</surname> <given-names>J. P.</given-names></name> <name><surname>Rojo</surname> <given-names>F.</given-names></name> <name><surname>Mart&#x00ED;nez</surname> <given-names>J. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>J. Bacteriol.</source> <volume>187</volume>, <fpage>1384</fpage>&#x2013;<lpage>1391</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.187.4.1384-1391.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15687203</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Huang</surname> <given-names>Z.</given-names></name> <name><surname>Ruan</surname> <given-names>B.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>M.</given-names></name> <name><surname>Rehman</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Quantitative proteomic analysis reveals the mechanisms of polymyxin B toxicity to <italic>Escherichia coli</italic></article-title>. <source>Chemosphere</source> <volume>259</volume>:<fpage>127449</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chemosphere.2020.127449</pub-id>, PMID: <pub-id pub-id-type="pmid">32622246</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Xiao</surname> <given-names>G.</given-names></name> <name><surname>Zhou</surname> <given-names>W.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Various novel colistin resistance mechanisms interact to facilitate adaptation of <italic>Aeromonas hydrophila</italic> to complex colistin environments</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>65</volume>:<fpage>e0007121</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00071-21</pub-id>, PMID: <pub-id pub-id-type="pmid">33903105</pub-id></citation></ref>
<ref id="ref0001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y. Y.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Walsh</surname> <given-names>T. R.</given-names></name> <name><surname>Yi</surname> <given-names>L. X.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Spencer</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study</article-title>. <source>Lancet Infect. Dis.</source> <volume>16</volume>, <fpage>161</fpage>&#x2013;<lpage>168</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1473-3099(15)00424-7</pub-id>, PMID: <pub-id pub-id-type="pmid">32622246</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>C. C.</given-names></name> <name><surname>Liao</surname> <given-names>W. Y.</given-names></name> <name><surname>Chou</surname> <given-names>M. C.</given-names></name> <name><surname>Wu</surname> <given-names>Y. Y.</given-names></name> <name><surname>Yeh</surname> <given-names>T. H.</given-names></name> <name><surname>Lo</surname> <given-names>H. R.</given-names></name></person-group> (<year>2022</year>). <article-title>Overexpression of resistance-nodulation-division efflux pump genes contributes to multidrug resistance in <italic>Aeromonas hydrophila</italic> clinical isolates</article-title>. <source>Microb. Drug Resist.</source> <volume>28</volume>, <fpage>153</fpage>&#x2013;<lpage>160</lpage>. doi: <pub-id pub-id-type="doi">10.1089/mdr.2021.0084</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lomovskaya</surname> <given-names>O.</given-names></name> <name><surname>Watkins</surname> <given-names>W. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Efflux pumps: their role in antibacterial drug discovery</article-title>. <source>Curr. Med. Chem.</source> <volume>8</volume>, <fpage>1699</fpage>&#x2013;<lpage>1711</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0929867013371743</pub-id>, PMID: <pub-id pub-id-type="pmid">11562289</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loutet</surname> <given-names>S. A.</given-names></name> <name><surname>Valvano</surname> <given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Extreme antimicrobial peptide and polymyxin B resistance in the genus burkholderia</article-title>. <source>Front. Microbiol.</source> <volume>2</volume>:<fpage>159</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2011.00159</pub-id>, PMID: <pub-id pub-id-type="pmid">21811491</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>S.</given-names></name> <name><surname>Zgurskaya</surname> <given-names>H. I.</given-names></name></person-group> (<year>2013</year>). <article-title>MacA, a periplasmic membrane fusion protein of the macrolide transporter MacAB-TolC, binds lipopolysaccharide core specifically and with high affinity</article-title>. <source>J. Bacteriol.</source> <volume>195</volume>, <fpage>4865</fpage>&#x2013;<lpage>4872</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00756-13</pub-id></citation></ref>
<ref id="ref004"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname> <given-names>L.</given-names></name> <name><surname>Wan</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Partridge</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Emergence of a plasmid-encoded resistance-nodulation-division efflux pump conferring resistance to multiple drugs, including tigecycline, in klebsiella pneumoniae</article-title>. <source>mBio.</source> <volume>11</volume>. doi: <pub-id pub-id-type="doi">10.1128/mBio.02930-19</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname> <given-names>F.</given-names></name> <name><surname>Cai</surname> <given-names>J.</given-names></name> <name><surname>He</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>W.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Overexpression of efflux pumps mediate Pan resistance of <italic>Klebsiella pneumoniae</italic> sequence type 11</article-title>. <source>Microb. Drug Resist.</source> <volume>27</volume>, <fpage>1405</fpage>&#x2013;<lpage>1411</lpage>. doi: <pub-id pub-id-type="doi">10.1089/mdr.2020.0395</pub-id>, PMID: <pub-id pub-id-type="pmid">33835874</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname> <given-names>D.</given-names></name> <name><surname>Antunes</surname> <given-names>J.</given-names></name> <name><surname>Sim&#x00F5;es</surname> <given-names>A.</given-names></name> <name><surname>Perdig&#x00E3;o</surname> <given-names>J.</given-names></name> <name><surname>Couto</surname> <given-names>I.</given-names></name> <name><surname>McCusker</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Contribution of efflux to colistin heteroresistance in a multidrug resistant <italic>Acinetobacter baumannii</italic> clinical isolate</article-title>. <source>J. Med. Microbiol.</source> <volume>67</volume>, <fpage>740</fpage>&#x2013;<lpage>749</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jmm.0.000741</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manjunath</surname> <given-names>A.</given-names></name> <name><surname>Thumu</surname> <given-names>S. C. R.</given-names></name> <name><surname>Kumar</surname> <given-names>S.</given-names></name> <name><surname>Halami</surname> <given-names>P. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Bacterial heteroresistance: an evolving novel way to combat antibiotics</article-title>. <source>Biologia (Bratisl.)</source> <volume>76</volume>, <fpage>3029</fpage>&#x2013;<lpage>3041</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11756-021-00820-y</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>R. G.</given-names></name> <name><surname>Gillette</surname> <given-names>W. K.</given-names></name> <name><surname>Rhee</surname> <given-names>S.</given-names></name> <name><surname>Rosner</surname> <given-names>J. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Structural requirements for marbox function in transcriptional activation of mar/sox/rob regulon promoters in <italic>Escherichia coli</italic>: sequence, orientation and spatial relationship to the core promoter</article-title>. <source>Mol. Microbiol.</source> <volume>34</volume>, <fpage>431</fpage>&#x2013;<lpage>441</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01599.x</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;nez-Servat</surname> <given-names>S.</given-names></name> <name><surname>Yero</surname> <given-names>D.</given-names></name> <name><surname>Huedo</surname> <given-names>P.</given-names></name> <name><surname>Marquez</surname> <given-names>R.</given-names></name> <name><surname>Molina</surname> <given-names>G.</given-names></name> <name><surname>Daura</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Heterogeneous colistin-resistance phenotypes coexisting in <italic>Stenotrophomonas maltophilia</italic> isolates influence colistin susceptibility testing</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>:<fpage>2871</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2018.02871</pub-id>, PMID: <pub-id pub-id-type="pmid">30524420</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname> <given-names>R.</given-names></name> <name><surname>Morrison</surname> <given-names>K. D.</given-names></name> <name><surname>Cho</surname> <given-names>H. J.</given-names></name> <name><surname>Khuu</surname> <given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Importance of real-time assays to distinguish multidrug efflux pump-inhibiting and outer membrane-destabilizing activities in <italic>Escherichia coli</italic></article-title>. <source>J. Bacteriol.</source> <volume>197</volume>, <fpage>2479</fpage>&#x2013;<lpage>2488</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.02456-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25962916</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mlynarcik</surname> <given-names>P.</given-names></name> <name><surname>Kolar</surname> <given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Molecular mechanisms of polymyxin resistance and detection of mcr genes</article-title>. <source>Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub.</source> <volume>163</volume>, <fpage>28</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.5507/bp.2018.070</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname> <given-names>J. H.</given-names></name> <name><surname>Harper</surname> <given-names>M.</given-names></name> <name><surname>Boyce</surname> <given-names>J. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Mechanisms of polymyxin resistance</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1145</volume>, <fpage>55</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-030-16373-0_5</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname> <given-names>J. H.</given-names></name> <name><surname>Harper</surname> <given-names>M.</given-names></name> <name><surname>Harrison</surname> <given-names>P.</given-names></name> <name><surname>Hale</surname> <given-names>J. D.</given-names></name> <name><surname>Vinogradov</surname> <given-names>E.</given-names></name> <name><surname>Seemann</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Colistin resistance in <italic>Acinetobacter baumannii</italic> is mediated by complete loss of lipopolysaccharide production</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4971</fpage>&#x2013;<lpage>4977</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00834-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20855724</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monta&#x00F1;a</surname> <given-names>S.</given-names></name> <name><surname>Vilacoba</surname> <given-names>E.</given-names></name> <name><surname>Traglia</surname> <given-names>G. M.</given-names></name> <name><surname>Almuzara</surname> <given-names>M.</given-names></name> <name><surname>Pennini</surname> <given-names>M.</given-names></name> <name><surname>Fern&#x00E1;ndez</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Genetic variability of AdeRS two-component system associated with tigecycline resistance in XDR-<italic>Acinetobacter baumannii</italic> isolates</article-title>. <source>Curr. Microbiol.</source> <volume>71</volume>, <fpage>76</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00284-015-0829-3</pub-id>, PMID: <pub-id pub-id-type="pmid">25941024</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname> <given-names>C.</given-names></name> <name><surname>Pl&#x00E9;siat</surname> <given-names>P.</given-names></name> <name><surname>Jeannot</surname> <given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and &#x03B2;-lactams in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>1211</fpage>&#x2013;<lpage>1221</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.01252-10</pub-id>, PMID: <pub-id pub-id-type="pmid">21149619</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naha</surname> <given-names>S.</given-names></name> <name><surname>Sands</surname> <given-names>K.</given-names></name> <name><surname>Mukherjee</surname> <given-names>S.</given-names></name> <name><surname>Dutta</surname> <given-names>S.</given-names></name> <name><surname>Basu</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>A 12 year experience of colistin resistance in <italic>Klebsiella pneumoniae</italic> causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>77</volume>, <fpage>1586</fpage>&#x2013;<lpage>1591</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkac083</pub-id>, PMID: <pub-id pub-id-type="pmid">35323923</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naha</surname> <given-names>S.</given-names></name> <name><surname>Sands</surname> <given-names>K.</given-names></name> <name><surname>Mukherjee</surname> <given-names>S.</given-names></name> <name><surname>Roy</surname> <given-names>C.</given-names></name> <name><surname>Rameez</surname> <given-names>M. J.</given-names></name> <name><surname>Saha</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>KPC-2-producing <italic>Klebsiella pneumoniae</italic> ST147 in a neonatal unit: clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>55</volume>:<fpage>105903</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105903</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Guan</surname> <given-names>J.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Cui</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>60</volume>, <fpage>3215</fpage>&#x2013;<lpage>3218</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00248-16</pub-id>, PMID: <pub-id pub-id-type="pmid">26953203</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishino</surname> <given-names>K.</given-names></name> <name><surname>Latifi</surname> <given-names>T.</given-names></name> <name><surname>Groisman</surname> <given-names>E. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Virulence and drug resistance roles of multidrug efflux systems of <italic>Salmonella enterica</italic> serovar typhimurium</article-title>. <source>Mol. Microbiol.</source> <volume>59</volume>, <fpage>126</fpage>&#x2013;<lpage>141</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04940.x</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishino</surname> <given-names>K.</given-names></name> <name><surname>Yamasaki</surname> <given-names>S.</given-names></name> <name><surname>Nakashima</surname> <given-names>R.</given-names></name> <name><surname>Zwama</surname> <given-names>M.</given-names></name> <name><surname>Hayashi-Nishino</surname> <given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Function and inhibitory mechanisms of multidrug efflux pumps</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>:<fpage>737288</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.737288</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname> <given-names>W.</given-names></name> <name><surname>Onishi</surname> <given-names>M.</given-names></name> <name><surname>Ni</surname> <given-names>R.</given-names></name> <name><surname>Tsuchiya</surname> <given-names>T.</given-names></name> <name><surname>Kuroda</surname> <given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional study of the novel multidrug efflux pump KexD from <italic>Klebsiella pneumoniae</italic></article-title>. <source>Gene</source> <volume>498</volume>, <fpage>177</fpage>&#x2013;<lpage>182</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gene.2012.02.008</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname> <given-names>J. T.</given-names></name> <name><surname>Cajal</surname> <given-names>Y.</given-names></name> <name><surname>Skowronska</surname> <given-names>E. M.</given-names></name> <name><surname>Belkin</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Van Dyk</surname> <given-names>T. K.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Cationic peptide antimicrobials induce selective transcription of micF and osmY in <italic>Escherichia coli</italic></article-title>. <source>Biochim. Biophys. Acta</source> <volume>1463</volume>, <fpage>43</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0005-2736(99)00177-7</pub-id></citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olaitan</surname> <given-names>A. O.</given-names></name> <name><surname>Morand</surname> <given-names>S.</given-names></name> <name><surname>Rolain</surname> <given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria</article-title>. <source>Front. Microbiol.</source> <volume>5</volume>:<fpage>643</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2014.00643</pub-id>, PMID: <pub-id pub-id-type="pmid">25505462</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osei Sekyere</surname> <given-names>J.</given-names></name> <name><surname>Amoako</surname> <given-names>D. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Carbonyl cyanide m-Chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>:<fpage>228</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.00228</pub-id>, PMID: <pub-id pub-id-type="pmid">28261184</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padilla</surname> <given-names>E.</given-names></name> <name><surname>Llobet</surname> <given-names>E.</given-names></name> <name><surname>Dom&#x00E9;nech-S&#x00E1;nchez</surname> <given-names>A.</given-names></name> <name><surname>Mart&#x00ED;nez-Mart&#x00ED;nez</surname> <given-names>L.</given-names></name> <name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>Albert&#x00ED;</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Klebsiella pneumoniae</italic> AcrAB efflux pump contributes to antimicrobial resistance and virulence</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>177</fpage>&#x2013;<lpage>183</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00715-09</pub-id></citation></ref>
<ref id="ref94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pamp</surname> <given-names>S. J.</given-names></name> <name><surname>Gjermansen</surname> <given-names>M.</given-names></name> <name><surname>Johansen</surname> <given-names>H. K.</given-names></name> <name><surname>Tolker-Nielsen</surname> <given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Tolerance to the antimicrobial peptide colistin in <italic>Pseudomonas aeruginosa</italic> biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes</article-title>. <source>Mol. Microbiol.</source> <volume>68</volume>, <fpage>223</fpage>&#x2013;<lpage>240</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06152.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18312276</pub-id></citation></ref>
<ref id="ref95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantel</surname> <given-names>L.</given-names></name> <name><surname>Juarez</surname> <given-names>P.</given-names></name> <name><surname>Serri</surname> <given-names>M.</given-names></name> <name><surname>Boucinha</surname> <given-names>L.</given-names></name> <name><surname>Lessoud</surname> <given-names>E.</given-names></name> <name><surname>Lanois</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Missense mutations in the CrrB protein mediate Odilorhabdin derivative resistance in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>65</volume>:<fpage>e00139-21</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00139-21</pub-id>, PMID: <pub-id pub-id-type="pmid">33685902</pub-id></citation></ref>
<ref id="ref96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>Y. K.</given-names></name> <name><surname>Ko</surname> <given-names>K. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing <italic>Acinetobacter baumannii</italic> by colistin</article-title>. <source>J. Microbiol.</source> <volume>53</volume>, <fpage>53</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12275-015-4498-5</pub-id>, PMID: <pub-id pub-id-type="pmid">25557480</pub-id></citation></ref>
<ref id="ref97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname> <given-names>D.</given-names></name> <name><surname>Mallick</surname> <given-names>S.</given-names></name> <name><surname>Das</surname> <given-names>S.</given-names></name> <name><surname>Saha</surname> <given-names>S.</given-names></name> <name><surname>Ghosh</surname> <given-names>A. K.</given-names></name> <name><surname>Mandal</surname> <given-names>S. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Colistin induced assortment of antimicrobial resistance in a clinical isolate of <italic>Acinetobacter baumannii</italic> SD01</article-title>. <source>Infect. Disord. Drug Targets</source> <volume>20</volume>, <fpage>501</fpage>&#x2013;<lpage>505</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1871526519666190426153258</pub-id></citation></ref>
<ref id="ref98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelling</surname> <given-names>H.</given-names></name> <name><surname>Bock</surname> <given-names>L. J.</given-names></name> <name><surname>Nzakizwanayo</surname> <given-names>J.</given-names></name> <name><surname>Wand</surname> <given-names>M. E.</given-names></name> <name><surname>Denham</surname> <given-names>E. L.</given-names></name> <name><surname>MacFarlane</surname> <given-names>W. M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>De-repression of the smvA efflux system arises in clinical isolates of <italic>Proteus mirabilis</italic> and reduces susceptibility to chlorhexidine and other biocides</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>:<fpage>e01535-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.01535-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31570392</pub-id></citation></ref>
<ref id="ref99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E9;rez</surname> <given-names>A.</given-names></name> <name><surname>Poza</surname> <given-names>M.</given-names></name> <name><surname>Fern&#x00E1;ndez</surname> <given-names>A.</given-names></name> <name><surname>Fern&#x00E1;ndez Mdel</surname> <given-names>C.</given-names></name> <name><surname>Mallo</surname> <given-names>S.</given-names></name> <name><surname>Merino</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of <italic>Enterobacter cloacae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>2084</fpage>&#x2013;<lpage>2090</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.05509-11</pub-id>, PMID: <pub-id pub-id-type="pmid">22290971</pub-id></citation></ref>
<ref id="ref100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piddock</surname> <given-names>L. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>19</volume>, <fpage>382</fpage>&#x2013;<lpage>402</lpage>. doi: <pub-id pub-id-type="doi">10.1128/cmr.19.2.382-402.2006</pub-id></citation></ref>
<ref id="ref101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname> <given-names>K.</given-names></name> <name><surname>Lau</surname> <given-names>C. H.</given-names></name> <name><surname>Gilmour</surname> <given-names>C.</given-names></name> <name><surname>Hao</surname> <given-names>Y.</given-names></name> <name><surname>Lam</surname> <given-names>J. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Polymyxin susceptibility in <italic>Pseudomonas aeruginosa</italic> linked to the MexXY-OprM multidrug efflux system</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>7276</fpage>&#x2013;<lpage>7289</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.01785-15</pub-id></citation></ref>
<ref id="ref102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname> <given-names>D.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Lu</surname> <given-names>B.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant <italic>Klebsiella pneumoniae</italic></article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>61</volume>:<fpage>106747</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2023.106747</pub-id>, PMID: <pub-id pub-id-type="pmid">36758779</pub-id></citation></ref>
<ref id="ref103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puja</surname> <given-names>H.</given-names></name> <name><surname>Bolard</surname> <given-names>A.</given-names></name> <name><surname>Nogu&#x00E8;s</surname> <given-names>A.</given-names></name> <name><surname>Pl&#x00E9;siat</surname> <given-names>P.</given-names></name> <name><surname>Jeannot</surname> <given-names>K.</given-names></name></person-group> (<year>2020</year>). <article-title>The efflux pump MexXY/OprM contributes to the tolerance and acquired resistance of <italic>Pseudomonas aeruginosa</italic> to colistin</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>64</volume>:<fpage>e02033-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.02033-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31964794</pub-id></citation></ref>
<ref id="ref104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puzari</surname> <given-names>M.</given-names></name> <name><surname>Chetia</surname> <given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>RND efflux pump mediated antibiotic resistance in gram-negative bacteria Escherichia coli and <italic>Pseudomonas aeruginosa</italic>: a major issue worldwide</article-title>. <source>World J. Microbiol. Biotechnol.</source> <volume>33</volume>:<fpage>24</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11274-016-2190-5</pub-id>, PMID: <pub-id pub-id-type="pmid">28044273</pub-id></citation></ref>
<ref id="ref105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname> <given-names>Z. A.</given-names></name> <name><surname>Hittle</surname> <given-names>L. E.</given-names></name> <name><surname>O'Hara</surname> <given-names>J. A.</given-names></name> <name><surname>Rivera</surname> <given-names>J. I.</given-names></name> <name><surname>Syed</surname> <given-names>A.</given-names></name> <name><surname>Shields</surname> <given-names>R. K.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Colistin-resistant <italic>Acinetobacter baumannii</italic>: beyond carbapenem resistance</article-title>. <source>Clin. Infect. Dis.</source> <volume>60</volume>, <fpage>1295</fpage>&#x2013;<lpage>1303</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/civ048</pub-id>, PMID: <pub-id pub-id-type="pmid">25632010</pub-id></citation></ref>
<ref id="ref106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname> <given-names>P. I.</given-names></name> <name><surname>Cust&#x00F3;dio</surname> <given-names>M. G.</given-names></name> <name><surname>Quispe Saji</surname> <given-names>G. D.</given-names></name> <name><surname>Cardoso</surname> <given-names>T.</given-names></name> <name><surname>da Silva</surname> <given-names>G. L.</given-names></name> <name><surname>Braun</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The polymyxin B-induced transcriptomic response of a clinical, multidrug-resistant <italic>Klebsiella pneumoniae</italic> involves multiple regulatory elements and intracellular targets</article-title>. <source>BMC Genomics</source> <volume>17</volume>:<fpage>737</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12864-016-3070-y</pub-id></citation></ref>
<ref id="ref107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richmond</surname> <given-names>G. E.</given-names></name> <name><surname>Evans</surname> <given-names>L. P.</given-names></name> <name><surname>Anderson</surname> <given-names>M. J.</given-names></name> <name><surname>Wand</surname> <given-names>M. E.</given-names></name> <name><surname>Bonney</surname> <given-names>L. C.</given-names></name> <name><surname>Ivens</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The <italic>Acinetobacter baumannii</italic> two-component system AdeRS regulates genes required for multidrug efflux, biofilm formation, and virulence in a strain-specific manner</article-title>. <source>MBio</source> <volume>7</volume>, <fpage>e00430</fpage>&#x2013;<lpage>e00416</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00430-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27094331</pub-id></citation></ref>
<ref id="ref108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosner</surname> <given-names>J. L.</given-names></name> <name><surname>Martin</surname> <given-names>R. G.</given-names></name></person-group> (<year>2009</year>). <article-title>An excretory function for the <italic>Escherichia coli</italic> outer membrane pore TolC: upregulation of marA and soxS transcription and rob activity due to metabolites accumulated in tolC mutants</article-title>. <source>J. Bacteriol.</source> <volume>191</volume>, <fpage>5283</fpage>&#x2013;<lpage>5292</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00507-09</pub-id></citation></ref>
<ref id="ref109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>Y.</given-names></name> <name><surname>Unno</surname> <given-names>Y.</given-names></name> <name><surname>Ubagai</surname> <given-names>T.</given-names></name> <name><surname>Ono</surname> <given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Sub-minimum inhibitory concentrations of colistin and polymyxin B promote <italic>Acinetobacter baumannii</italic> biofilm formation</article-title>. <source>PLoS One</source> <volume>13</volume>:<fpage>e0194556</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0194556</pub-id></citation></ref>
<ref id="ref002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>Y.</given-names></name> <name><surname>Lv</surname> <given-names>Z.</given-names></name> <name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Ou</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Integrated aquaculture contributes to the transfer of mcr-1 between animals and humans via the aquaculture supply chain</article-title>. <source>Environ. Int.</source> <volume>130</volume>: <fpage>104708</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envint.2019.03.056</pub-id>, PMID: <pub-id pub-id-type="pmid">27094331</pub-id></citation></ref>
<ref id="ref110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shenkutie</surname> <given-names>A. M.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Yao</surname> <given-names>M.</given-names></name> <name><surname>Asrat</surname> <given-names>D.</given-names></name> <name><surname>Chow</surname> <given-names>F. W. N.</given-names></name> <name><surname>Leung</surname> <given-names>P. H. M.</given-names></name></person-group> (<year>2022</year>). <article-title>Effects of sub-minimum inhibitory concentrations of imipenem and colistin on expression of biofilm-specific antibiotic resistance and virulence genes in <italic>Acinetobacter baumannii</italic> sequence type 1894</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:<fpage>12705</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms232012705</pub-id>, PMID: <pub-id pub-id-type="pmid">36293559</pub-id></citation></ref>
<ref id="ref111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirshikova</surname> <given-names>T. V.</given-names></name> <name><surname>Sierra-Bakhshi</surname> <given-names>C. G.</given-names></name> <name><surname>Kamaletdinova</surname> <given-names>L. K.</given-names></name> <name><surname>Matrosova</surname> <given-names>L. E.</given-names></name> <name><surname>Khabipova</surname> <given-names>N. N.</given-names></name> <name><surname>Evtugyn</surname> <given-names>V. G.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The ABC-type efflux pump MacAB is involved in protection of <italic>Serratia marcescens</italic> against aminoglycoside antibiotics, polymyxins, and oxidative stress</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>6</volume>:<fpage>e00033-21</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mSphere.00033-21</pub-id>, PMID: <pub-id pub-id-type="pmid">33692192</pub-id></citation></ref>
<ref id="ref112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>V. B.</given-names></name> <name><surname>Rajamohan</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>KpnEF, a new member of the <italic>Klebsiella pneumoniae</italic> cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>57</volume>, <fpage>4449</fpage>&#x2013;<lpage>4462</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.02284-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23836167</pub-id></citation></ref>
<ref id="ref113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>V. B.</given-names></name> <name><surname>Singh</surname> <given-names>B. B.</given-names></name> <name><surname>Priyadarshi</surname> <given-names>N.</given-names></name> <name><surname>Chauhan</surname> <given-names>N. K.</given-names></name> <name><surname>Rajamohan</surname> <given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of novel multidrug efflux pump involved in drug resistance in <italic>Klebsiella pneumoniae</italic></article-title>. <source>PLoS One</source> <volume>9</volume>:<fpage>e96288</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0096288</pub-id>, PMID: <pub-id pub-id-type="pmid">24823362</pub-id></citation></ref>
<ref id="ref114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>S.</given-names></name> <name><surname>Gao</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Jin</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Emerg. Microbes Infect.</source> <volume>9</volume>, <fpage>1102</fpage>&#x2013;<lpage>1113</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2020.1768805</pub-id></citation></ref>
<ref id="ref115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L.</given-names></name> <name><surname>Rasmussen</surname> <given-names>P. K.</given-names></name> <name><surname>Bai</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Cai</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Proteomic changes of <italic>Klebsiella pneumoniae</italic> in response to colistin treatment and crrB mutation-mediated colistin resistance</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>64</volume>:<fpage>e02200-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.02200-19</pub-id>, PMID: <pub-id pub-id-type="pmid">32229491</pub-id></citation></ref>
<ref id="ref116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundaramoorthy</surname> <given-names>N. S.</given-names></name> <name><surname>Mohan</surname> <given-names>H. M.</given-names></name> <name><surname>Subramaniam</surname> <given-names>S.</given-names></name> <name><surname>Raman</surname> <given-names>T.</given-names></name> <name><surname>Selva Ganesan</surname> <given-names>S.</given-names></name> <name><surname>Sivasubamanian</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019a</year>). <article-title>Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae</article-title>. <source>AMB Express</source> <volume>9</volume>:<fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13568-019-0750-4</pub-id>, PMID: <pub-id pub-id-type="pmid">30778773</pub-id></citation></ref>
<ref id="ref117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundaramoorthy</surname> <given-names>N. S.</given-names></name> <name><surname>Suresh</surname> <given-names>P.</given-names></name> <name><surname>Selva Ganesan</surname> <given-names>S.</given-names></name> <name><surname>GaneshPrasad</surname> <given-names>A.</given-names></name> <name><surname>Nagarajan</surname> <given-names>S.</given-names></name></person-group> (<year>2019b</year>). <article-title>Restoring colistin sensitivity in colistin-resistant <italic>E. coli</italic>: combinatorial use of MarR inhibitor with efflux pump inhibitor</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>19845</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-56325-x</pub-id></citation></ref>
<ref id="ref118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tag ElDein</surname> <given-names>M. A.</given-names></name> <name><surname>Yassin</surname> <given-names>A. S.</given-names></name> <name><surname>El-Tayeb</surname> <given-names>O.</given-names></name> <name><surname>Kashef</surname> <given-names>M. T.</given-names></name></person-group> (<year>2021</year>). <article-title>Chlorhexidine leads to the evolution of antibiotic-resistant <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>40</volume>, <fpage>2349</fpage>&#x2013;<lpage>2361</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10096-021-04292-5</pub-id></citation></ref>
<ref id="ref119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Telke</surname> <given-names>A. A.</given-names></name> <name><surname>Olaitan</surname> <given-names>A. O.</given-names></name> <name><surname>Morand</surname> <given-names>S.</given-names></name> <name><surname>Rolain</surname> <given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>soxRS induces colistin hetero-resistance in Enterobacter asburiae and <italic>Enterobacter cloacae</italic> by regulating the acrAB-tolC efflux pump</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>72</volume>, <fpage>2715</fpage>&#x2013;<lpage>2721</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkx215</pub-id>, PMID: <pub-id pub-id-type="pmid">29091215</pub-id></citation></ref>
<ref id="ref120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thi Khanh Nhu</surname> <given-names>N.</given-names></name> <name><surname>Riordan</surname> <given-names>D. W.</given-names></name> <name><surname>do Hoang Nhu</surname> <given-names>T.</given-names></name> <name><surname>Thanh</surname> <given-names>D. P.</given-names></name> <name><surname>Thwaites</surname> <given-names>G.</given-names></name> <name><surname>Huong Lan</surname> <given-names>N. P.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The induction and identification of novel colistin resistance mutations in <italic>Acinetobacter baumannii</italic> and their implications</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>28291</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep28291</pub-id>, PMID: <pub-id pub-id-type="pmid">27329501</pub-id></citation></ref>
<ref id="ref121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tzeng</surname> <given-names>Y. L.</given-names></name> <name><surname>Ambrose</surname> <given-names>K. D.</given-names></name> <name><surname>Zughaier</surname> <given-names>S.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Miller</surname> <given-names>Y. K.</given-names></name> <name><surname>Shafer</surname> <given-names>W. M.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Cationic antimicrobial peptide resistance in <italic>Neisseria meningitidis</italic></article-title>. <source>J. Bacteriol.</source> <volume>187</volume>, <fpage>5387</fpage>&#x2013;<lpage>5396</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.187.15.5387-5396.2005</pub-id></citation></ref>
<ref id="ref122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wadsworth</surname> <given-names>C. B.</given-names></name> <name><surname>Arnold</surname> <given-names>B. J.</given-names></name> <name><surname>Sater</surname> <given-names>M. R. A.</given-names></name> <name><surname>Grad</surname> <given-names>Y. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Azithromycin resistance through interspecific Acquisition of an Epistasis-Dependent Efflux Pump Component and Transcriptional Regulator in <italic>Neisseria gonorrhoeae</italic></article-title>. <source>MBio</source> <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.1128/mBio.01419-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30087172</pub-id></citation></ref>
<ref id="ref123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wand</surname> <given-names>M. E.</given-names></name> <name><surname>Jamshidi</surname> <given-names>S.</given-names></name> <name><surname>Bock</surname> <given-names>L. J.</given-names></name> <name><surname>Rahman</surname> <given-names>K. M.</given-names></name> <name><surname>Sutton</surname> <given-names>J. M.</given-names></name></person-group> (<year>2019</year>). <article-title>SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other Enterobacteriaceae</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>1344</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-37730-0</pub-id>, PMID: <pub-id pub-id-type="pmid">30718598</pub-id></citation></ref>
<ref id="ref124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Qi</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>R.</given-names></name> <name><surname>Jin</surname> <given-names>L.</given-names></name> <name><surname>Zhao</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative <italic>Klebsiella pneumoniae</italic></article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>50</volume>, <fpage>536</fpage>&#x2013;<lpage>541</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.05.009</pub-id></citation></ref>
<ref id="ref125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname> <given-names>D. M.</given-names></name> <name><surname>Levy</surname> <given-names>S. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Different effects of transcriptional regulators MarA, SoxS and rob on susceptibility of <italic>Escherichia coli</italic> to cationic antimicrobial peptides (CAMPs): rob-dependent CAMP induction of the marRAB operon</article-title>. <source>Microbiology (Read.)</source> <volume>156</volume>, <fpage>570</fpage>&#x2013;<lpage>578</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.033415-0</pub-id>, PMID: <pub-id pub-id-type="pmid">19926649</pub-id></citation></ref>
<ref id="ref126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Worthington</surname> <given-names>R. J.</given-names></name> <name><surname>Blackledge</surname> <given-names>M. S.</given-names></name> <name><surname>Melander</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence</article-title>. <source>Future Med. Chem.</source> <volume>5</volume>, <fpage>1265</fpage>&#x2013;<lpage>1284</lpage>. doi: <pub-id pub-id-type="doi">10.4155/fmc.13.58</pub-id>, PMID: <pub-id pub-id-type="pmid">23859207</pub-id></citation></ref>
<ref id="ref127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Q. E.</given-names></name> <name><surname>MacLean</surname> <given-names>C.</given-names></name> <name><surname>Papkou</surname> <given-names>A.</given-names></name> <name><surname>Pritchard</surname> <given-names>M.</given-names></name> <name><surname>Powell</surname> <given-names>L.</given-names></name> <name><surname>Thomas</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Compensatory mutations modulate the competitiveness an dynamics of plasmid-mediated colistin resistance in <italic>Escherichia coli</italic> clones</article-title>. <source>ISME J.</source> <volume>14</volume>, <fpage>861</fpage>&#x2013;<lpage>865</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41396-019-0578-6</pub-id></citation></ref>
<ref id="ref128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>G.</given-names></name> <name><surname>Lin</surname> <given-names>M.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>He</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Molecular characterization of carbapenem-resistant and virulent plasmids in <italic>Klebsiella pneumoniae</italic> from patients with bloodstream infections in China</article-title>. <source>Emerg. Microbes. Infect.</source> <volume>10</volume>, <fpage>700</fpage>&#x2013;<lpage>709</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2021.1906163</pub-id>, PMID: <pub-id pub-id-type="pmid">33739229</pub-id></citation></ref>
<ref id="ref129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname> <given-names>&#x015E;.</given-names></name> <name><surname>Hasdemir</surname> <given-names>U.</given-names></name> <name><surname>Aksu</surname> <given-names>B.</given-names></name> <name><surname>Alt&#x0131;nkanat Gelmez</surname> <given-names>G.</given-names></name> <name><surname>S&#x00F6;yletir</surname> <given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>Alterations in AdeS and AdeR regulatory proteins in 1-(1-naphthylmethyl)-piperazine responsive colistin resistance of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Chemother.</source> <volume>32</volume>, <fpage>286</fpage>&#x2013;<lpage>293</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1120009x.2020.1735118</pub-id>, PMID: <pub-id pub-id-type="pmid">32131715</pub-id></citation></ref>
<ref id="ref130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>E. J.</given-names></name> <name><surname>Balloy</surname> <given-names>V.</given-names></name> <name><surname>Fiette</surname> <given-names>L.</given-names></name> <name><surname>Chignard</surname> <given-names>M.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Grillot-Courvalin</surname> <given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Contribution of the Ade resistance-nodulation-cell division-type efflux pumps to fitness and pathogenesis of <italic>Acinetobacter baumannii</italic></article-title>. <source>MBio</source> <volume>7</volume>:<fpage>e00697-16</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00697-16</pub-id></citation></ref>
<ref id="ref131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yousefian</surname> <given-names>N.</given-names></name> <name><surname>Ornik-Cha</surname> <given-names>A.</given-names></name> <name><surname>Poussard</surname> <given-names>S.</given-names></name> <name><surname>Decossas</surname> <given-names>M.</given-names></name> <name><surname>Berbon</surname> <given-names>M.</given-names></name> <name><surname>Daury</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Structural characterization of the EmrAB-TolC efflux complex from <italic>E. coli</italic></article-title>. <source>Biochim. Biophys. Acta Biomembr.</source> <volume>1863</volume>:<fpage>183488</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamem.2020.183488</pub-id>, PMID: <pub-id pub-id-type="pmid">33065135</pub-id></citation></ref>
<ref id="ref132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Z.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Fu</surname> <given-names>J.</given-names></name> <name><surname>Qiu</surname> <given-names>J.</given-names></name> <name><surname>Yin</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Enhanced NADH metabolism involves colistin-induced killing of Bacillus subtilis and <italic>Paenibacillus polymyxa</italic></article-title>. <source>Molecules</source> <volume>24</volume>:<fpage>387</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules24030387</pub-id>, PMID: <pub-id pub-id-type="pmid">30678237</pub-id></citation></ref>
<ref id="ref133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>X.</given-names></name> <name><surname>Hinenoya</surname> <given-names>A.</given-names></name> <name><surname>Guan</surname> <given-names>Z.</given-names></name> <name><surname>Xu</surname> <given-names>F.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Critical role of the RpoE stress response pathway in polymyxin resistance of <italic>Escherichia coli</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>78</volume>, <fpage>732</fpage>&#x2013;<lpage>746</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkad003</pub-id></citation></ref>
<ref id="ref134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zgurskaya</surname> <given-names>H. I.</given-names></name> <name><surname>Krishnamoorthy</surname> <given-names>G.</given-names></name> <name><surname>Ntreh</surname> <given-names>A.</given-names></name> <name><surname>Lu</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Mechanism and function of the outer Membrane Channel TolC in multidrug resistance and physiology of enterobacteria</article-title>. <source>Front. Microbiol.</source> <volume>2</volume>:<fpage>189</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2011.00189</pub-id></citation></ref>
<ref id="ref135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>Y. J.</given-names></name> <name><surname>Huang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Sun</surname> <given-names>H. R.</given-names></name> <name><surname>He</surname> <given-names>D.</given-names></name> <name><surname>Pan</surname> <given-names>Y. S.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>CpxR overexpression increases the susceptibility of acrB and cpxR double-deleted <italic>Salmonella enterica</italic> serovar typhimurium to colistin</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>3016</fpage>&#x2013;<lpage>3024</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dky320</pub-id>, PMID: <pub-id pub-id-type="pmid">30107570</pub-id></citation></ref>
<ref id="ref136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>A.</given-names></name> <name><surname>Rosner</surname> <given-names>J. L.</given-names></name> <name><surname>Martin</surname> <given-names>R. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Transcriptional activation by MarA, SoxS and rob of two tolC promoters using one binding site: a complex promoter configuration for tolC in <italic>Escherichia coli</italic></article-title>. <source>Mol. Microbiol.</source> <volume>69</volume>, <fpage>1450</fpage>&#x2013;<lpage>1455</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06371.x</pub-id></citation></ref>
<ref id="ref137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Yuan</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Deng</surname> <given-names>B.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>Comparative transcription analysis of resistant mutants against four different antibiotics in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Microb. Pathog.</source> <volume>160</volume>:<fpage>105166</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micpath.2021.105166</pub-id>, PMID: <pub-id pub-id-type="pmid">34480983</pub-id></citation></ref>
<ref id="ref138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M. K.</given-names></name> <name><surname>Zhang</surname> <given-names>M. Y.</given-names></name> <name><surname>Liu</surname> <given-names>S. B.</given-names></name> <name><surname>Yang</surname> <given-names>Y. Y.</given-names></name> <name><surname>Zhai</surname> <given-names>Y. J.</given-names></name> <name><surname>He</surname> <given-names>D. D.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Double deletion of cpxR and tolC significantly increases the susceptibility of <italic>Salmonella enterica</italic> serovar typhimurium to colistin</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>76</volume>, <fpage>3168</fpage>&#x2013;<lpage>3174</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkab332</pub-id>, PMID: <pub-id pub-id-type="pmid">34499729</pub-id></citation></ref>
<ref id="ref139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Duan</surname> <given-names>S.</given-names></name> <name><surname>Kang</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Antimicrobial activity of colistin against contemporary (2015 - 2017) P. aeruginosa and <italic>A. baumannii</italic> isolates from a Chinese surveillance program</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>1966</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.01966</pub-id>, PMID: <pub-id pub-id-type="pmid">33013738</pub-id></citation></ref>
<ref id="ref140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zoaiter</surname> <given-names>M.</given-names></name> <name><surname>Zeaiter</surname> <given-names>Z.</given-names></name> <name><surname>Mediannikov</surname> <given-names>O.</given-names></name> <name><surname>Sokhna</surname> <given-names>C.</given-names></name> <name><surname>Fournier</surname> <given-names>P. E.</given-names></name></person-group> (<year>2023</year>). <article-title>Carbonyl cyanide 3-Chloro phenyl hydrazone (CCCP) restores the colistin sensitivity in brucella intermedia</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>:<fpage>2106</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24032106</pub-id>, PMID: <pub-id pub-id-type="pmid">36768429</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pathogens/refgene/#mcr" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pathogens/refgene/#mcr</ext-link>
</p>
</fn>
</fn-group>
</back>
</article>